<?xml version="1.0" ?><targets><program pid="2">FeatureAlign</program><query>c1cc(ccc1c1cn(c2c1c(=N)n(cn2)N)c1ccc(cc1)Cl)Cl	ZINC03852046
</query><species-list><species name="homo sapiens" value="51"/><species name="other species" value="5"/></species-list><target confirm="Predicted" fun="catalytic activity" geneid="1017" genename="CDK2" genesyn="None" proc="regulation of biological process" rank="1" score="1.0" simiscore="1.382" species="Homo sapiens" uniprot="P24941"><name>Cell division protein kinase 2</name><function>Involved in the control of the cell cycle. Interacts with cyclins A, B1, B3, D, or E. Activity of CDK2 is maximal during S phase and G2.</function><go_list><go branch="BP" id="GO:0000086">G2/M transition of mitotic cell cycle</go><go branch="BP" id="GO:0007067">mitosis</go><go branch="BP" id="GO:0007089">traversing start control point of mitotic c...</go><go branch="BP" id="GO:0006260">cellular DNA replication</go><go branch="BP" id="GO:0007265">Ras protein signal transduction</go><go branch="BP" id="GO:0008284">positive regulation of cell proliferation</go><go branch="BP" id="GO:0051301">cell division</go><go branch="BP" id="GO:0006275">regulation of DNA replication</go><go branch="CC" id="GO:0005829">cytosol</go><go branch="CC" id="GO:0000307">cyclin-dependent protein kinase holoenzyme ...</go><go branch="MF" id="GO:0042802">identical protein binding</go><go branch="MF" id="GO:0005524">ATP binding</go><go branch="MF" id="GO:0004693">cyclin-dependent protein kinase activity</go></go_list><pathway_list><react id="REACT_115566" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_115566">Cell Cycle</react><react id="REACT_383" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_383">DNA Replication</react><react id="REACT_604" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_604">Hemostasis</react><react id="REACT_111183" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111183">Meiosis</react></pathway_list><compounds><compound id="DB08694" score="1.382" srcdb="DrugBank" srcid="DB08694"><name>9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol</name><SMILES>NC1=NC(=CC=N1)C1=C2C=CN=C(N)N2C2=C1C(O)=CC=N2</SMILES><effect></effect><activities/></compound><compound id="DB08178" score="1.292" srcdb="DrugBank" srcid="DB08178"><name>4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine</name><SMILES>COC1=C2C(NC=C2C2=CC=NC(N)=N2)=NC=C1</SMILES><effect></effect><activities/></compound><compound id="DB08182" score="1.247" srcdb="DrugBank" srcid="DB08182"><name>4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine</name><SMILES>CCCOC1=C2C(NC=C2C2=CC=NC(N)=N2)=NC=C1</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="catalytic activity" geneid="None" genename="DFR1" genesyn="None" proc="cellular process" rank="2" score="0.938" simiscore="1.241" species="Candida albicans" uniprot="P22906"><name>Dihydrofolate reductase</name><function>Key enzyme in folate metabolism. Catalyzes an essential reaction for de novo glycine and purine synthesis, and for DNA precursor synthesis.</function><go_list><go branch="BP" id="GO:0006545">glycine biosynthetic process</go><go branch="BP" id="GO:0009165">nucleotide biosynthetic process</go><go branch="BP" id="GO:0055114">oxidation reduction</go><go branch="BP" id="GO:0006730">one-carbon metabolic process</go><go branch="MF" id="GO:0050661">NADP or NADPH binding</go><go branch="MF" id="GO:0004146">dihydrofolate reductase activity</go></go_list><pathway_list/><compounds><compound id="DB04163" score="1.241" srcdb="DrugBank" srcid="DB04163"><name>5-Phenylsulfanyl-2,4-Quinazolinediamine</name><SMILES>NC1=NC2=C(C(SC3=CC=CC=C3)=CC=C2)C(N)=N1</SMILES><effect></effect><activities/></compound><compound id="DB02402" score="1.232" srcdb="DrugBank" srcid="DB02402"><name>5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine</name><SMILES>COC1=CC=C(OC2=CC=CC3=C2C(N)=NC(N)=N3)C=C1</SMILES><effect></effect><activities/></compound><compound id="DB04306" score="1.213" srcdb="DrugBank" srcid="DB04306"><name>5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine</name><SMILES>CC1=CC=C(SC2=CC=CC3=C2C(N)=NC(N)=N3)C=C1</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="catalytic activity" geneid="3055" genename="HCK" genesyn="None" proc="multi-organism process" rank="3" score="0.391" simiscore="1.615" species="Homo sapiens" uniprot="P08631"><name>Tyrosine-protein kinase HCK</name><function>May serve as part of a signaling pathway coupling the Fc receptor to the activation of the respiratory burst. May also contribute to neutrophil migration and may regulate the degranulation process of neutrophils.</function><go_list><go branch="BP" id="GO:0007498">mesoderm development</go><go branch="BP" id="GO:0044419">interspecies interaction between organisms</go><go branch="BP" id="GO:0006468">protein amino acid phosphorylation</go><go branch="CC" id="GO:0005737">cytoplasm</go><go branch="CC" id="GO:0016020">membrane</go><go branch="MF" id="GO:0005515">protein binding</go><go branch="MF" id="GO:0004715">non-membrane spanning protein tyrosine kina...</go><go branch="MF" id="GO:0005524">ATP binding</go></go_list><pathway_list><react id="REACT_116125" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_116125">Disease</react><react id="REACT_6900" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_6900">Immune System</react></pathway_list><compounds><compound id="DB01809" score="1.615" srcdb="DrugBank" srcid="DB01809"><name>1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine</name><SMILES>CC1=CC=C(C=C1)C1=NN(C2=C1C(N)=NC=N2)C(C)(C)C</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="catalytic activity" geneid="5294" genename="PIK3CG" genesyn="None" proc="response to stimulus" rank="4" score="0.366" simiscore="1.521" species="Homo sapiens" uniprot="P48736"><name>Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform</name><function>3-phosphorylates the cellular phosphoinositide PtdIns- 4,5-biphosphate (PtdIns(4,5)P2) to produce PtdIns-3, 4,5- triiphosphate (PtdIns(3,4,5)P3). Links G-protein coupled receptor activation to the secondary messenger PtdIns(3,4,5)P3 production.</function><go_list><go branch="BP" id="GO:0048015">phosphoinositide-mediated signaling</go><go branch="BP" id="GO:0007186">G-protein coupled receptor protein signalin...</go><go branch="BP" id="GO:0046854">phosphoinositide phosphorylation</go><go branch="CC" id="GO:0005942">phosphoinositide 3-kinase complex</go><go branch="MF" id="GO:0005515">protein binding</go><go branch="MF" id="GO:0016303">1-phosphatidylinositol-3-kinase activity</go><go branch="MF" id="GO:0046934">phosphatidylinositol-4,5-bisphosphate 3-kin...</go><go branch="MF" id="GO:0005524">ATP binding</go></go_list><pathway_list><react id="REACT_604" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_604">Hemostasis</react><react id="REACT_111217" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111217">Metabolism</react><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB07335" score="1.521" srcdb="DrugBank" srcid="DB07335"><name>3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL</name><SMILES>CC(C)N1N=C(C2=C1N=CN=C2N)C1=CC(O)=CC=C1</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="catalytic activity" geneid="9261" genename="MAPKAPK2" genesyn="None" proc="cellular process" rank="5" score="0.318" simiscore="1.339" species="Homo sapiens" uniprot="P49137"><name>MAP kinase-activated protein kinase 2</name><function>Its physiological substrate seems to be the small heat shock protein (HSP27/HSP25). In vitro can phosphorylate glycogen synthase at 'Ser-7' and tyrosine hydroxylase (on 'Ser-19' and 'Ser-40'). This kinase phosphorylates Ser in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue (By similarity). Mediates both ERK and p38 MAPK/MAPK14 dependent neutrophil responses. Participates in TNF alpha-stimulated exocytosis of secretory vesicles in neutrophils. Plays a role in phagocytosis-induced respiratory burst activity.</function><go_list><go branch="BP" id="GO:0000165">MAPKKK cascade</go><go branch="BP" id="GO:0006468">protein amino acid phosphorylation</go><go branch="BP" id="GO:0007265">Ras protein signal transduction</go><go branch="CC" id="GO:0005829">cytosol</go><go branch="CC" id="GO:0005634">nucleus</go><go branch="MF" id="GO:0005524">ATP binding</go><go branch="MF" id="GO:0005515">protein binding</go><go branch="MF" id="GO:0004674">protein serine/threonine kinase activity</go><go branch="MF" id="GO:0004871">signal transducer activity</go></go_list><pathway_list><react id="REACT_71" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_71">Gene Expression</react><react id="REACT_6900" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_6900">Immune System</react><react id="REACT_111217" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111217">Metabolism</react><react id="REACT_21257" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_21257">Metabolism of RNA</react><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react><react id="REACT_6782" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_6782">TRAF6 Mediated Induction of proinflammatory cytokines</react></pathway_list><compounds><compound id="DB07728" score="1.339" srcdb="DrugBank" srcid="DB07728"><name>2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</name><SMILES>FC1=C(C=CC=C1)C1=CC(=CC=N1)C1=CC2=C(CCNC2=O)N1</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="nucleic acid binding transcription factor activity" geneid="2099" genename="ESR1" genesyn="None" proc="regulation of biological process" rank="6" score="0.294" simiscore="1.248" species="Homo sapiens" uniprot="P03372"><name>Estrogen receptor</name><function>Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Can activate the transcriptional activity of TFF1.</function><go_list><go branch="BP" id="GO:0030520">estrogen receptor signaling pathway</go><go branch="BP" id="GO:0006351">cellular transcription, DNA-dependent</go><go branch="BP" id="GO:0006355">regulation of cellular transcription, DNA-d...</go><go branch="BP" id="GO:0048386">positive regulation of retinoic acid recept...</go><go branch="CC" id="GO:0016585">chromatin remodeling complex</go><go branch="MF" id="GO:0030284">estrogen receptor activity</go><go branch="MF" id="GO:0005496">steroid binding</go><go branch="MF" id="GO:0008270">zinc ion binding</go><go branch="MF" id="GO:0034056">estrogen response element binding</go><go branch="MF" id="GO:0030235">nitric-oxide synthase regulator activity</go><go branch="MF" id="GO:0003700">transcription factor activity</go><go branch="MF" id="GO:0005515">protein binding</go></go_list><pathway_list><react id="REACT_71" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_71">Gene Expression</react><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB08047" score="1.248" srcdb="DrugBank" srcid="DB08047"><name>4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol</name><SMILES>OC1=CC(O)=C(C=C1)C1=NN(CC=C)C2=C1C=CC=C2C(F)(F)F</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="binding" geneid="2155" genename="F7" genesyn="None" proc="response to stimulus" rank="7" score="0.288" simiscore="1.226" species="Homo sapiens" uniprot="P08709"><name>Coagulation factor VII</name><function>Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa will also convert factor IX to factor IXa in the presence of tissue factor and calcium.</function><go_list><go branch="BP" id="GO:0007598">blood coagulation, extrinsic pathway</go><go branch="BP" id="GO:0006508">proteolysis</go><go branch="BP" id="GO:0002690">positive regulation of leukocyte chemotaxis</go><go branch="BP" id="GO:0050927">positive regulation of positive chemotaxis</go><go branch="BP" id="GO:0051897">positive regulation of protein kinase B sig...</go><go branch="BP" id="GO:0010641">positive regulation of platelet-derived gro...</go><go branch="BP" id="GO:0006916">anti-apoptosis</go><go branch="CC" id="GO:0005886">plasma membrane</go><go branch="CC" id="GO:0005576">extracellular region</go><go branch="MF" id="GO:0005509">calcium ion binding</go><go branch="MF" id="GO:0004252">serine-type endopeptidase activity</go><go branch="MF" id="GO:0001948">glycoprotein binding</go></go_list><pathway_list><react id="REACT_24941" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_24941">Circadian Clock</react><react id="REACT_604" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_604">Hemostasis</react><react id="REACT_17015" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_17015">Metabolism of proteins</react></pathway_list><compounds><compound id="DB08232" score="1.226" srcdb="DrugBank" srcid="DB08232"><name>{5-(5-AMINO-1H-PYRROLO[3,2-B]PYRIDIN-2-YL)-6-HYDROXY-3'-NITRO-BIPHENYL-3-YL]-ACETIC ACID</name><SMILES>NC1=CC=C2NC(=CC2=N1)C1=CC(CC(O)=O)=CC(C2=CC=CC(=C2)[N+]([O-])=O)=C1O</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="catalytic activity" geneid="5743" genename="PTGS2" genesyn="COX2" proc="regulation of biological process" rank="8" score="0.285" simiscore="1.213" species="Homo sapiens" uniprot="P35354"><name>Prostaglandin G/H synthase 2</name><function>May have a role as a major mediator of inflammation and/or a role for prostanoid signaling in activity-dependent plasticity.</function><go_list><go branch="BP" id="GO:0050727">regulation of inflammatory response</go><go branch="BP" id="GO:0008217">regulation of blood pressure</go><go branch="BP" id="GO:0019371">cyclooxygenase pathway</go><go branch="BP" id="GO:0055114">oxidation reduction</go><go branch="BP" id="GO:0006928">cellular component movement</go><go branch="BP" id="GO:0006979">response to oxidative stress</go><go branch="CC" id="GO:0005788">endoplasmic reticulum lumen</go><go branch="CC" id="GO:0005789">endoplasmic reticulum membrane</go><go branch="CC" id="GO:0005792">microsome</go><go branch="CC" id="GO:0005634">nucleus</go><go branch="MF" id="GO:0020037">heme binding</go><go branch="MF" id="GO:0016702">oxidoreductase activity, acting on single d...</go><go branch="MF" id="GO:0004666">prostaglandin-endoperoxide synthase activity</go><go branch="MF" id="GO:0004601">peroxidase activity</go></go_list><pathway_list><react id="REACT_111217" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111217">Metabolism</react></pathway_list><compounds><compound id="DB00861" score="1.213" srcdb="DrugBank" srcid="DB00861"><name>Diflunisal</name><SMILES>OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For symptomatic treatment of mild to moderate pain accompanied by inflammation (e.g. musculoskeletal trauma, post-dental extraction, post-episiotomy), osteoarthritis, and rheumatoid arthritis.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;The precise mechanism of the analgesic and anti-inflammatory actions of diflunisal is not known. Diflunisal is a prostaglandin synthetase inhibitor. In animals, prostaglandins sensitize afferent nerves and potentiate the action of bradykinin in inducing pain. Since prostaglandins are known to be among the mediators of pain and inflammation, the mode of action of diflunisal may be due to a decrease of prostaglandins in peripheral tissues.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="catalytic activity" geneid="5292" genename="PIM1" genesyn="None" proc="cellular process" rank="9" score="0.285" simiscore="1.215" species="Homo sapiens" uniprot="P11309"><name>Proto-oncogene serine/threonine-protein kinase Pim-1</name><function>May affect the structure or silencing of chromatin by phosphorylating HP1 gamma/CBX3. Isoform 2 promotes the G1/S transition of the cell cycle via up-regulation of CDK2 activity and phosphorylation of CDKN1B, resulting in enhanced nuclear export and proteasome-dependent degradation of CDKN1B. Isoform 2 also represses CDKN1B transcription by phosphorylating and inactivating the transcription factor FOXO3. Plays a role in signal transduction in blood cells. Contributes to both cell proliferation and survival and thus provides a selective advantage in tumorigenesis.</function><go_list><go branch="BP" id="GO:0008283">cell proliferation</go><go branch="BP" id="GO:0006468">protein amino acid phosphorylation</go><go branch="BP" id="GO:0007049">cell cycle</go><go branch="BP" id="GO:0007275">multicellular organismal development</go><go branch="BP" id="GO:0043066">negative regulation of apoptosis</go><go branch="BP" id="GO:0046777">protein amino acid autophosphorylation</go><go branch="BP" id="GO:0043433">negative regulation of transcription factor...</go><go branch="BP" id="GO:0031659">positive regulation of cyclin-dependent pro...</go><go branch="CC" id="GO:0005886">plasma membrane</go><go branch="CC" id="GO:0005737">cytoplasm</go><go branch="CC" id="GO:0005634">nucleus</go><go branch="MF" id="GO:0005524">ATP binding</go><go branch="MF" id="GO:0030145">manganese ion binding</go><go branch="MF" id="GO:0008134">transcription factor binding</go><go branch="MF" id="GO:0004674">protein serine/threonine kinase activity</go><go branch="MF" id="GO:0005515">protein binding</go></go_list><pathway_list/><compounds><compound id="DB02656" score="1.215" srcdb="DrugBank" srcid="DB02656"><name>2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One</name><SMILES>O=C1C=C(OC2=C1C=CC=C2C1=CC=CC=C1)N1CCOCC1</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="catalytic activity" geneid="2147" genename="F2" genesyn="None" proc="regulation of biological process" rank="10" score="0.227" simiscore="1.258" species="Homo sapiens" uniprot="P00734"><name>Prothrombin</name><function>Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostasis, inflammation and wound healing.</function><go_list><go branch="BP" id="GO:0051209">release of sequestered calcium ion into cyt...</go><go branch="BP" id="GO:0030168">platelet activation</go><go branch="BP" id="GO:0007262">STAT protein nuclear translocation</go><go branch="BP" id="GO:0051281">positive regulation of release of sequester...</go><go branch="BP" id="GO:0030194">positive regulation of blood coagulation</go><go branch="BP" id="GO:0006508">proteolysis</go><go branch="BP" id="GO:0007275">multicellular organismal development</go><go branch="BP" id="GO:0042730">fibrinolysis</go><go branch="BP" id="GO:0006919">activation of caspase activity</go><go branch="BP" id="GO:0001934">positive regulation of protein amino acid p...</go><go branch="BP" id="GO:0007260">tyrosine phosphorylation of STAT protein</go><go branch="BP" id="GO:0006953">acute-phase response</go><go branch="BP" id="GO:0032967">positive regulation of collagen biosyntheti...</go><go branch="BP" id="GO:0007166">cell surface receptor linked signaling pathway</go><go branch="CC" id="GO:0005886">plasma membrane</go><go branch="CC" id="GO:0005615">extracellular space</go><go branch="CC" id="GO:0005625">soluble fraction</go><go branch="MF" id="GO:0070053">thrombospondin receptor activity</go><go branch="MF" id="GO:0005509">calcium ion binding</go><go branch="MF" id="GO:0005102">receptor binding</go><go branch="MF" id="GO:0004252">serine-type endopeptidase activity</go></go_list><pathway_list><react id="REACT_116125" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_116125">Disease</react><react id="REACT_604" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_604">Hemostasis</react><react id="REACT_17015" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_17015">Metabolism of proteins</react><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB03159" score="1.258" srcdb="DrugBank" srcid="DB03159"><name>CRA_8696</name><SMILES>NC(=[NH2+])C1=CC=C2NC(=CC2=C1)C1=CC=CC(C2=CC=CC=C2)=C1[O-]</SMILES><effect></effect><activities/></compound><compound id="DB03865" score="1.228" srcdb="DrugBank" srcid="DB03865"><name>6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine</name><SMILES>NC(=[NH2+])C1=C(Cl)C=C2NC(=CC2=C1)C1=CC=CC(C2=CC=CC=C2)=C1O</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="catalytic activity" geneid="5644" genename="PRSS1" genesyn="None" proc="multicellular organismal process" rank="11" score="0.227" simiscore="1.258" species="Homo sapiens" uniprot="P07477"><name>Trypsin-1</name><function>Has activity against the synthetic substrates Boc-Phe- Ser-Arg-Mec, Boc-Leu-Thr-Arg-Mec, Boc-Gln-Ala-Arg-Mec and Boc-Val- Pro-Arg-Mec. The single-chain form is more active than the two- chain form against all of these substrates.</function><go_list><go branch="BP" id="GO:0007586">digestion</go><go branch="BP" id="GO:0006508">proteolysis</go><go branch="CC" id="GO:0005615">extracellular space</go><go branch="MF" id="GO:0005515">protein binding</go><go branch="MF" id="GO:0004252">serine-type endopeptidase activity</go><go branch="MF" id="GO:0005509">calcium ion binding</go></go_list><pathway_list><react id="REACT_118779" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_118779">Extracellular matrix organization</react></pathway_list><compounds><compound id="DB03159" score="1.258" srcdb="DrugBank" srcid="DB03159"><name>CRA_8696</name><SMILES>NC(=[NH2+])C1=CC=C2NC(=CC2=C1)C1=CC=CC(C2=CC=CC=C2)=C1[O-]</SMILES><effect></effect><activities/></compound><compound id="DB03865" score="1.228" srcdb="DrugBank" srcid="DB03865"><name>6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine</name><SMILES>NC(=[NH2+])C1=C(Cl)C=C2NC(=CC2=C1)C1=CC=CC(C2=CC=CC=C2)=C1O</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="binding" geneid="3932" genename="LCK" genesyn="None" proc="cellular process" rank="12" score="0.172" simiscore="1.572" species="Homo sapiens" uniprot="P06239"><name>Proto-oncogene tyrosine-protein kinase LCK</name><function>Tyrosine kinase that plays an essential role for the selection and maturation of developing T-cell in the thymus and in mature T-cell function. Is constitutively associated with the cytoplasmic portions of the CD4 and CD8 surface receptors and plays a key role in T-cell antigen receptor(TCR)-linked signal transduction pathways. Association of the TCR with a peptide antigen-bound MHC complex facilitates the interaction of CD4 and CD8 with MHC class II and class I molecules, respectively, and thereby recruits the associated LCK to the vicinity of the TCR/CD3 complex. LCK then phosphorylates tyrosines residues within the immunoreceptor tyrosines-based activation motifs (ITAMs) in the cytoplasmic tails of the TCRgamma chains and CD3 subunits, initiating the TCR/CD3 signaling pathway. In addition, contributes to signaling by other receptor molecules. Associates directly with the cytoplasmic tail of CD2, and upon engagement of the CD2 molecule, LCK undergoes hyperphosphorylation and activation. Also plays a role in the IL2 receptor-linked signaling pathway that controls T-cell proliferative response. Binding of IL2 to its receptor results in increased activity of LCK. Is expressed at all stages of thymocyte development and is required for the regulation of maturation events that are governed by both pre-TCR and mature alpha beta TCR.</function><go_list><go branch="BP" id="GO:0006468">protein amino acid phosphorylation</go><go branch="BP" id="GO:0030217">T cell differentiation</go><go branch="BP" id="GO:0006917">induction of apoptosis</go><go branch="BP" id="GO:0006919">activation of caspase activity</go><go branch="BP" id="GO:0042493">response to drug</go><go branch="BP" id="GO:0006882">cellular zinc ion homeostasis</go><go branch="BP" id="GO:0044419">interspecies interaction between organisms</go><go branch="BP" id="GO:0050862">positive regulation of T cell receptor sign...</go><go branch="BP" id="GO:0050870">positive regulation of T cell activation</go><go branch="BP" id="GO:0051209">release of sequestered calcium ion into cyt...</go><go branch="CC" id="GO:0005886">plasma membrane</go><go branch="CC" id="GO:0000242">pericentriolar material</go><go branch="CC" id="GO:0045121">membrane raft</go><go branch="CC" id="GO:0005794">Golgi apparatus</go><go branch="CC" id="GO:0005829">cytosol</go><go branch="MF" id="GO:0005524">ATP binding</go><go branch="MF" id="GO:0004715">non-membrane spanning protein tyrosine kina...</go><go branch="MF" id="GO:0019901">protein kinase binding</go><go branch="MF" id="GO:0004722">protein serine/threonine phosphatase activity</go><go branch="MF" id="GO:0042609">CD4 receptor binding</go><go branch="MF" id="GO:0042169">SH2 domain binding</go><go branch="MF" id="GO:0051117">ATPase binding</go><go branch="MF" id="GO:0008022">protein C-terminus binding</go><go branch="MF" id="GO:0042610">CD8 receptor binding</go><go branch="MF" id="GO:0001948">glycoprotein binding</go><go branch="MF" id="GO:0043548">phosphoinositide 3-kinase binding</go></go_list><pathway_list><react id="REACT_116125" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_116125">Disease</react><react id="REACT_604" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_604">Hemostasis</react><react id="REACT_6900" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_6900">Immune System</react><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB03023" score="1.572" srcdb="DrugBank" srcid="DB03023"><name>1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine</name><SMILES>CC(C)(C)N1[NH+]=C(C2=C1N=CN=C2N)C1=CC=C(Cl)C=C1</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="molecular transducer activity" geneid="4067" genename="LYN" genesyn="None" proc="regulation of biological process" rank="13" score="0.172" simiscore="1.572" species="Homo sapiens" uniprot="P07948"><name>Tyrosine-protein kinase Lyn</name><function>Down regulates expression of stem cell growth factor receptor (KIT). Acts as an effector of EpoR (erythropoietin receptor) in controlling KIT expression and may play a central role in erythroid differentiation during the switch between proliferation and maturation (By similarity). Acts as a positive regulator of cell movement while negatively regulating adhesion to stromal cells by inhibiting the ICAM-1-binding activity of beta-2 integrins. Acts as the mediator that relays suppressing signals from the chemokine receptor CXCR4 to beta-2 integrin LFA-1 in hematopoietic precursors. Involved in induction of stress- activated protein kinase (SAPK), but not ERK or p38 MAPK, in response to genotoxic agents. Induces SAPK by a MKK7- and MEKK1- dependent mechanism. The LYN -&gt; MEKK1 -&gt; MKK7 -&gt; SAPK pathway is functional in the induction of apoptosis by genotoxic agents.</function><go_list><go branch="BP" id="GO:0030218">erythrocyte differentiation</go><go branch="BP" id="GO:0051272">positive regulation of cellular component m...</go><go branch="BP" id="GO:0070304">positive regulation of stress-activated pro...</go><go branch="BP" id="GO:0044419">interspecies interaction between organisms</go><go branch="BP" id="GO:0006974">response to DNA damage stimulus</go><go branch="BP" id="GO:0042531">positive regulation of tyrosine phosphoryla...</go><go branch="CC" id="GO:0005829">cytosol</go><go branch="CC" id="GO:0048471">perinuclear region of cytoplasm</go><go branch="CC" id="GO:0005634">nucleus</go><go branch="CC" id="GO:0045121">membrane raft</go><go branch="CC" id="GO:0005794">Golgi apparatus</go><go branch="MF" id="GO:0005524">ATP binding</go><go branch="MF" id="GO:0004716">receptor signaling protein tyrosine kinase ...</go><go branch="MF" id="GO:0004715">non-membrane spanning protein tyrosine kina...</go></go_list><pathway_list><react id="REACT_604" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_604">Hemostasis</react><react id="REACT_6900" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_6900">Immune System</react><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB03023" score="1.572" srcdb="DrugBank" srcid="DB03023"><name>1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine</name><SMILES>CC(C)(C)N1[NH+]=C(C2=C1N=CN=C2N)C1=CC=C(Cl)C=C1</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="catalytic activity" geneid="5141" genename="PDE4A" genesyn="DPDE2" proc="response to stimulus" rank="14" score="0.135" simiscore="1.295" species="Homo sapiens" uniprot="P27815"><name>cAMP-specific 3',5'-cyclic phosphodiesterase 4A</name><function>Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes.</function><go_list><go branch="BP" id="GO:0007165">signal transduction</go><go branch="CC" id="GO:0005624">membrane fraction</go><go branch="CC" id="GO:0005829">cytosol</go><go branch="CC" id="GO:0048471">perinuclear region of cytoplasm</go><go branch="CC" id="GO:0005625">soluble fraction</go><go branch="CC" id="GO:0032587">ruffle membrane</go><go branch="MF" id="GO:0046872">metal ion binding</go><go branch="MF" id="GO:0005515">protein binding</go><go branch="MF" id="GO:0004115">3',5'-cyclic-AMP phosphodiesterase activity</go></go_list><pathway_list><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB08299" score="1.295" srcdb="DrugBank" srcid="DB08299"><name>4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid</name><SMILES>OC(=O)C1=CC=C(C=C1)C1=NC(C2=CC=CC(=C2)[N+]([O-])=O)=C2N=CC=CC2=C1</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="binding" geneid="4010703" genename="bphC" genesyn="None" proc="cellular process" rank="15" score="0.135" simiscore="1.293" species="Burkholderia xenovorans" uniprot="P47228"><name>Biphenyl-2,3-diol 1,2-dioxygenase</name><function>Shows a preference for catechols with groups immediately adjacent to the hydroxyl substituents.</function><go_list><go branch="BP" id="GO:0019439">aromatic compound catabolic process</go><go branch="BP" id="GO:0042178">xenobiotic catabolic process</go><go branch="BP" id="GO:0055114">oxidation reduction</go><go branch="MF" id="GO:0018583">biphenyl-2,3-diol 1,2-dioxygenase activity</go><go branch="MF" id="GO:0008198">ferrous iron binding</go></go_list><pathway_list/><compounds><compound id="DB02923" score="1.293" srcdb="DrugBank" srcid="DB02923"><name>Biphenyl-2,3-Diol</name><SMILES>OC1=C(O)C(=CC=C1)C1=CC=CC=C1</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="binding" geneid="None" genename="bphC" genesyn="None" proc="cellular process" rank="16" score="0.135" simiscore="1.293" species="Pseudomonas sp." uniprot="P17297"><name>Biphenyl-2,3-diol 1,2-dioxygenase</name><function/><go_list><go branch="BP" id="GO:0019439">aromatic compound catabolic process</go><go branch="BP" id="GO:0042178">xenobiotic catabolic process</go><go branch="BP" id="GO:0055114">oxidation reduction</go><go branch="MF" id="GO:0018583">biphenyl-2,3-diol 1,2-dioxygenase activity</go><go branch="MF" id="GO:0008198">ferrous iron binding</go></go_list><pathway_list/><compounds><compound id="DB02923" score="1.293" srcdb="DrugBank" srcid="DB02923"><name>Biphenyl-2,3-Diol</name><SMILES>OC1=C(O)C(=CC=C1)C1=CC=CC=C1</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="catalytic activity" geneid="5142" genename="PDE4B" genesyn="DPDE4" proc="response to stimulus" rank="17" score="0.135" simiscore="1.295" species="Homo sapiens" uniprot="Q07343"><name>cAMP-specific 3',5'-cyclic phosphodiesterase 4B</name><function>Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. May be involved in mediating central nervous system effects of therapeutic agents ranging from antidepressants to antiasthmatic and anti-inflammatory agents.</function><go_list><go branch="BP" id="GO:0007165">signal transduction</go><go branch="CC" id="GO:0005829">cytosol</go><go branch="CC" id="GO:0005625">soluble fraction</go><go branch="CC" id="GO:0005626">insoluble fraction</go><go branch="MF" id="GO:0046872">metal ion binding</go><go branch="MF" id="GO:0004115">3',5'-cyclic-AMP phosphodiesterase activity</go></go_list><pathway_list><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB08299" score="1.295" srcdb="DrugBank" srcid="DB08299"><name>4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid</name><SMILES>OC(=O)C1=CC=C(C=C1)C1=NC(C2=CC=CC(=C2)[N+]([O-])=O)=C2N=CC=CC2=C1</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="catalytic activity" geneid="5328" genename="PLAU" genesyn="None" proc="metabolic process" rank="18" score="0.096" simiscore="1.228" species="Homo sapiens" uniprot="P00749"><name>Urokinase-type plasminogen activator</name><function>Specifically cleave the zymogen plasminogen to form the active enzyme plasmin.</function><go_list><go branch="BP" id="GO:0006508">proteolysis</go><go branch="BP" id="GO:0006935">chemotaxis</go><go branch="BP" id="GO:0007596">blood coagulation</go><go branch="BP" id="GO:0007165">signal transduction</go><go branch="BP" id="GO:0042730">fibrinolysis</go><go branch="CC" id="GO:0005886">plasma membrane</go><go branch="CC" id="GO:0005576">extracellular region</go><go branch="MF" id="GO:0004252">serine-type endopeptidase activity</go></go_list><pathway_list><react id="REACT_604" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_604">Hemostasis</react></pathway_list><compounds><compound id="DB03865" score="1.228" srcdb="DrugBank" srcid="DB03865"><name>6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine</name><SMILES>NC(=[NH2+])C1=C(Cl)C=C2NC(=CC2=C1)C1=CC=CC(C2=CC=CC=C2)=C1O</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="binding" geneid="3717" genename="JAK2" genesyn="None" proc="developmental process" rank="19" score="0.047" simiscore="1.258" species="Homo sapiens" uniprot="O60674"><name>Tyrosine-protein kinase JAK2</name><function>Plays a role in leptin signaling and control of body weight (By similarity). Tyrosine kinase of the non-receptor type, involved in interleukin-3 and probably interleukin-23 signal transduction.</function><go_list><go branch="BP" id="GO:0042517">positive regulation of tyrosine phosphoryla...</go><go branch="BP" id="GO:0046677">response to antibiotic</go><go branch="BP" id="GO:0042523">positive regulation of tyrosine phosphoryla...</go><go branch="BP" id="GO:0006928">cellular component movement</go><go branch="BP" id="GO:0007498">mesoderm development</go><go branch="CC" id="GO:0012505">endomembrane system</go><go branch="CC" id="GO:0005856">cytoskeleton</go><go branch="MF" id="GO:0005131">growth hormone receptor binding</go><go branch="MF" id="GO:0004715">non-membrane spanning protein tyrosine kina...</go><go branch="MF" id="GO:0042169">SH2 domain binding</go><go branch="MF" id="GO:0005524">ATP binding</go></go_list><pathway_list><react id="REACT_604" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_604">Hemostasis</react><react id="REACT_6900" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_6900">Immune System</react><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB04716" score="1.258" srcdb="DrugBank" srcid="DB04716"><name>2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE</name><SMILES>CC(C)(C)C1=NC2=C3C=CC(F)=CC3=C3C(=O)NC=CC3=C2N1</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="catalytic activity" geneid="3718" genename="JAK3" genesyn="None" proc="cellular process" rank="20" score="0.047" simiscore="1.258" species="Homo sapiens" uniprot="P52333"><name>Tyrosine-protein kinase JAK3</name><function>Tyrosine kinase of the non-receptor type, involved in the interleukin-2 and interleukin-4 signaling pathway. Phosphorylates STAT6, IRS1, IRS2 and PI3K.</function><go_list><go branch="BP" id="GO:0018108">peptidyl-tyrosine phosphorylation</go><go branch="BP" id="GO:0007243">protein kinase cascade</go><go branch="CC" id="GO:0012505">endomembrane system</go><go branch="CC" id="GO:0016020">membrane</go><go branch="CC" id="GO:0005856">cytoskeleton</go><go branch="MF" id="GO:0005515">protein binding</go><go branch="MF" id="GO:0004718">Janus kinase activity</go><go branch="MF" id="GO:0004715">non-membrane spanning protein tyrosine kina...</go><go branch="MF" id="GO:0005524">ATP binding</go></go_list><pathway_list><react id="REACT_6900" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_6900">Immune System</react></pathway_list><compounds><compound id="DB04716" score="1.258" srcdb="DrugBank" srcid="DB04716"><name>2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE</name><SMILES>CC(C)(C)C1=NC2=C3C=CC(F)=CC3=C3C(=O)NC=CC3=C2N1</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="catalytic activity" geneid="3716" genename="JAK1" genesyn="None" proc="response to stimulus" rank="21" score="0.047" simiscore="1.258" species="Homo sapiens" uniprot="P23458"><name>Tyrosine-protein kinase JAK1</name><function>Tyrosine kinase of the non-receptor type, involved in the IFN-alpha/beta/gamma signal pathway. Kinase partner for the interleukin (IL)-2 receptor.</function><go_list><go branch="BP" id="GO:0046677">response to antibiotic</go><go branch="CC" id="GO:0005856">cytoskeleton</go><go branch="CC" id="GO:0005634">nucleus</go><go branch="CC" id="GO:0016020">membrane</go><go branch="CC" id="GO:0005737">cytoplasm</go><go branch="CC" id="GO:0012505">endomembrane system</go><go branch="MF" id="GO:0005131">growth hormone receptor binding</go><go branch="MF" id="GO:0005524">ATP binding</go><go branch="MF" id="GO:0004718">Janus kinase activity</go><go branch="MF" id="GO:0004715">non-membrane spanning protein tyrosine kina...</go></go_list><pathway_list><react id="REACT_6900" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_6900">Immune System</react></pathway_list><compounds><compound id="DB04716" score="1.258" srcdb="DrugBank" srcid="DB04716"><name>2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE</name><SMILES>CC(C)(C)C1=NC2=C3C=CC(F)=CC3=C3C(=O)NC=CC3=C2N1</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="catalytic activity" geneid="1613" genename="DAPK3" genesyn="ZIPK" proc="regulation of biological process" rank="22" score="0.047" simiscore="1.258" species="Homo sapiens" uniprot="O43293"><name>Death-associated protein kinase 3</name><function>Serine/threonine kinase which acts as a positive regulator of apoptosis. Phosphorylates histone H3 on 'Thr-11' at centromeres during mitosis. Regulates myosin light chain phosphatase through phosphorylation of MYPT1 thereby regulating the assembly of the actin cytoskeleton, cell migration, invasiveness of tumor cells, smooth muscle contraction and neurite outgrowth.</function><go_list><go branch="BP" id="GO:0016568">chromatin modification</go><go branch="BP" id="GO:0006915">apoptosis</go><go branch="BP" id="GO:0007243">protein kinase cascade</go><go branch="BP" id="GO:0006917">induction of apoptosis</go><go branch="BP" id="GO:0006468">protein amino acid phosphorylation</go><go branch="CC" id="GO:0005737">cytoplasm</go><go branch="CC" id="GO:0005634">nucleus</go><go branch="MF" id="GO:0043522">leucine zipper domain binding</go><go branch="MF" id="GO:0004674">protein serine/threonine kinase activity</go><go branch="MF" id="GO:0005524">ATP binding</go></go_list><pathway_list><react id="REACT_578" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_578">Apoptosis</react></pathway_list><compounds><compound id="DB04716" score="1.258" srcdb="DrugBank" srcid="DB04716"><name>2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE</name><SMILES>CC(C)(C)C1=NC2=C3C=CC(F)=CC3=C3C(=O)NC=CC3=C2N1</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="molecular transducer activity" geneid="5916" genename="RARG" genesyn="NR1B3" proc="regulation of biological process" rank="23" score="0.037" simiscore="1.376" species="Homo sapiens" uniprot="P13631"><name>Retinoic acid receptor gamma-1</name><function>This is a receptor for retinoic acid. This metabolite has profound effects on vertebrate development. Retinoic acid is a morphogen and is a powerful teratogen. This receptor controls cell function by directly regulating gene expression.</function><go_list><go branch="BP" id="GO:0032526">response to retinoic acid</go><go branch="BP" id="GO:0048384">retinoic acid receptor signaling pathway</go><go branch="BP" id="GO:0045944">positive regulation of transcription from R...</go><go branch="BP" id="GO:0006350">cellular transcription</go><go branch="BP" id="GO:0008361">regulation of cell size</go><go branch="BP" id="GO:0060070">Wnt receptor signaling pathway through beta...</go><go branch="BP" id="GO:0043065">positive regulation of apoptosis</go><go branch="BP" id="GO:0035116">embryonic hindlimb morphogenesis</go><go branch="BP" id="GO:0008285">negative regulation of cell proliferation</go><go branch="BP" id="GO:0048048">embryonic eye morphogenesis</go><go branch="BP" id="GO:0000122">negative regulation of transcription from R...</go><go branch="CC" id="GO:0005667">transcription factor complex</go><go branch="CC" id="GO:0016021">integral to membrane</go><go branch="MF" id="GO:0008270">zinc ion binding</go><go branch="MF" id="GO:0046965">retinoid X receptor binding</go><go branch="MF" id="GO:0003707">steroid hormone receptor activity</go><go branch="MF" id="GO:0003700">transcription factor activity</go><go branch="MF" id="GO:0043565">sequence-specific DNA binding</go><go branch="MF" id="GO:0003708">retinoic acid receptor activity</go></go_list><pathway_list><react id="REACT_71" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_71">Gene Expression</react></pathway_list><compounds><compound id="DB00210" score="1.376" srcdb="DrugBank" srcid="DB00210"><name>Adapalene</name><SMILES>COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the topical treatment of comedo, papular and pustular acne (acne vulgaris) of the face, chest or back.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;Mechanistically, adapalene binds to specific retinoic acid nuclear receptors (gamma and beta) and retinoid X receptors but does not bind to the cytosolic receptor protein. Although the exact mode of action of adapalene is unknown, it is suggested that topical adapalene may normalize the differentiation of follicular epithelial cells resulting in decreased microcomedone formation.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="molecular transducer activity" geneid="5914" genename="RARA" genesyn="NR1B1" proc="response to stimulus" rank="24" score="0.037" simiscore="1.376" species="Homo sapiens" uniprot="P10276"><name>Retinoic acid receptor alpha</name><function>This is a receptor for retinoic acid. Retinoic acid has profound effects on vertebrate development, is a morphogen and is a powerful teratogen. This receptor controls cell function by directly regulating gene expression. Regulates expression of target genes in a ligand-dependent manner by recruiting chromatin complexes containing MLL5. Mediates retinoic acid-induced granulopoiesis.</function><go_list><go branch="BP" id="GO:0030520">estrogen receptor signaling pathway</go><go branch="BP" id="GO:0032720">negative regulation of tumor necrosis facto...</go><go branch="BP" id="GO:0048384">retinoic acid receptor signaling pathway</go><go branch="BP" id="GO:0032736">positive regulation of interleukin-13 produ...</go><go branch="BP" id="GO:0045630">positive regulation of T-helper 2 cell diff...</go><go branch="BP" id="GO:0032753">positive regulation of interleukin-4 produc...</go><go branch="BP" id="GO:0032689">negative regulation of interferon-gamma pro...</go><go branch="BP" id="GO:0006350">cellular transcription</go><go branch="BP" id="GO:0006355">regulation of cellular transcription, DNA-d...</go><go branch="BP" id="GO:0032355">response to estradiol stimulus</go><go branch="BP" id="GO:0032754">positive regulation of interleukin-5 produc...</go><go branch="BP" id="GO:0032526">response to retinoic acid</go><go branch="CC" id="GO:0005634">nucleus</go><go branch="CC" id="GO:0009986">cell surface</go><go branch="MF" id="GO:0003707">steroid hormone receptor activity</go><go branch="MF" id="GO:0003713">transcription coactivator activity</go><go branch="MF" id="GO:0043565">sequence-specific DNA binding</go><go branch="MF" id="GO:0003708">retinoic acid receptor activity</go><go branch="MF" id="GO:0008270">zinc ion binding</go><go branch="MF" id="GO:0001972">retinoic acid binding</go><go branch="MF" id="GO:0003700">transcription factor activity</go></go_list><pathway_list><react id="REACT_71" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_71">Gene Expression</react></pathway_list><compounds><compound id="DB00210" score="1.376" srcdb="DrugBank" srcid="DB00210"><name>Adapalene</name><SMILES>COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the topical treatment of comedo, papular and pustular acne (acne vulgaris) of the face, chest or back.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;Mechanistically, adapalene binds to specific retinoic acid nuclear receptors (gamma and beta) and retinoid X receptors but does not bind to the cytosolic receptor protein. Although the exact mode of action of adapalene is unknown, it is suggested that topical adapalene may normalize the differentiation of follicular epithelial cells resulting in decreased microcomedone formation.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="molecular transducer activity" geneid="5915" genename="RARB" genesyn="None" proc="Other" rank="25" score="0.037" simiscore="1.376" species="Homo sapiens" uniprot="P10826"><name>Retinoic acid receptor beta</name><function>This is a receptor for retinoic acid. This metabolite has profound effects on vertebrate development. Retinoic acid is a morphogen and is a powerful teratogen. This receptor controls cell function by directly regulating gene expression.</function><go_list><go branch="BP" id="GO:0006350">cellular transcription</go><go branch="BP" id="GO:0007165">signal transduction</go><go branch="CC" id="GO:0005634">nucleus</go><go branch="CC" id="GO:0005737">cytoplasm</go><go branch="MF" id="GO:0003707">steroid hormone receptor activity</go><go branch="MF" id="GO:0003708">retinoic acid receptor activity</go><go branch="MF" id="GO:0008270">zinc ion binding</go></go_list><pathway_list><react id="REACT_71" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_71">Gene Expression</react></pathway_list><compounds><compound id="DB00210" score="1.376" srcdb="DrugBank" srcid="DB00210"><name>Adapalene</name><SMILES>COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the topical treatment of comedo, papular and pustular acne (acne vulgaris) of the face, chest or back.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;Mechanistically, adapalene binds to specific retinoic acid nuclear receptors (gamma and beta) and retinoid X receptors but does not bind to the cytosolic receptor protein. Although the exact mode of action of adapalene is unknown, it is suggested that topical adapalene may normalize the differentiation of follicular epithelial cells resulting in decreased microcomedone formation.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="binding" geneid="6258" genename="RXRG" genesyn="NR2B3" proc="Other" rank="26" score="0.037" simiscore="1.376" species="Homo sapiens" uniprot="P48443"><name>Retinoic acid receptor RXR-gamma</name><function>Nuclear hormone receptor. Involved in the retinoic acid response pathway. Binds 9-cis retinoic acid (9C-RA) (By similarity).</function><go_list><go branch="BP" id="GO:0006350">cellular transcription</go><go branch="CC" id="GO:0005634">nucleus</go><go branch="MF" id="GO:0008270">zinc ion binding</go><go branch="MF" id="GO:0003707">steroid hormone receptor activity</go><go branch="MF" id="GO:0003700">transcription factor activity</go><go branch="MF" id="GO:0005496">steroid binding</go><go branch="MF" id="GO:0004886">retinoid-X receptor activity</go></go_list><pathway_list><react id="REACT_71" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_71">Gene Expression</react></pathway_list><compounds><compound id="DB00210" score="1.376" srcdb="DrugBank" srcid="DB00210"><name>Adapalene</name><SMILES>COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the topical treatment of comedo, papular and pustular acne (acne vulgaris) of the face, chest or back.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;Mechanistically, adapalene binds to specific retinoic acid nuclear receptors (gamma and beta) and retinoid X receptors but does not bind to the cytosolic receptor protein. Although the exact mode of action of adapalene is unknown, it is suggested that topical adapalene may normalize the differentiation of follicular epithelial cells resulting in decreased microcomedone formation.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="binding" geneid="6257" genename="RXRB" genesyn="NR2B2" proc="regulation of biological process" rank="27" score="0.037" simiscore="1.376" species="Homo sapiens" uniprot="P28702"><name>Retinoic acid receptor RXR-beta</name><function>Nuclear hormone receptor. Involved in the retinoic acid response pathway. Binds 9-cis retinoic acid (9C-RA).</function><go_list><go branch="BP" id="GO:0006355">regulation of cellular transcription, DNA-d...</go><go branch="BP" id="GO:0006350">cellular transcription</go><go branch="CC" id="GO:0005634">nucleus</go><go branch="MF" id="GO:0003706">ligand-regulated transcription factor activity</go><go branch="MF" id="GO:0008270">zinc ion binding</go><go branch="MF" id="GO:0005496">steroid binding</go><go branch="MF" id="GO:0004886">retinoid-X receptor activity</go><go branch="MF" id="GO:0003713">transcription coactivator activity</go><go branch="MF" id="GO:0003700">transcription factor activity</go><go branch="MF" id="GO:0043565">sequence-specific DNA binding</go><go branch="MF" id="GO:0003707">steroid hormone receptor activity</go></go_list><pathway_list><react id="REACT_71" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_71">Gene Expression</react></pathway_list><compounds><compound id="DB00210" score="1.376" srcdb="DrugBank" srcid="DB00210"><name>Adapalene</name><SMILES>COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the topical treatment of comedo, papular and pustular acne (acne vulgaris) of the face, chest or back.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;Mechanistically, adapalene binds to specific retinoic acid nuclear receptors (gamma and beta) and retinoid X receptors but does not bind to the cytosolic receptor protein. Although the exact mode of action of adapalene is unknown, it is suggested that topical adapalene may normalize the differentiation of follicular epithelial cells resulting in decreased microcomedone formation.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="Other" geneid="1816" genename="DRD5" genesyn="None" proc="cellular process" rank="28" score="0.036" simiscore="1.226" species="Homo sapiens" uniprot="P21918"><name>D(1B) dopamine receptor</name><function>This is one of the five types (D1 to D5) of receptors for dopamine. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase.</function><go_list><go branch="BP" id="GO:0006800">oxygen and reactive oxygen species metaboli...</go><go branch="BP" id="GO:0006874">cellular calcium ion homeostasis</go><go branch="BP" id="GO:0033861">negative regulation of NAD(P)H oxidase acti...</go><go branch="BP" id="GO:0060158">activation of phospholipase C activity by d...</go><go branch="BP" id="GO:0001963">synaptic transmission, dopaminergic</go><go branch="BP" id="GO:0007191">activation of adenylate cyclase activity by...</go><go branch="CC" id="GO:0005887">integral to plasma membrane</go></go_list><pathway_list><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB00800" score="1.226" srcdb="DrugBank" srcid="DB00800"><name>Fenoldopam</name><SMILES>OC1=CC=C(C=C1)C1CNCCC2=C1C=C(O)C(O)=C2Cl</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the in-hospital, short-term (up to 48 hours) management of severe hypertension when rapid, but quickly reversible, emergency reduction of blood pressure is clinically indicated, including malignant hypertension with deteriorating end-organ function.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;Fenoldopam is a rapid-acting vasodilator. It is an agonist for D&lt;sub&gt;1&lt;/sub&gt;-like dopamine receptors and binds with moderate affinity to &amp;alpha;&lt;sub&gt;2&lt;/sub&gt;-adrenoceptors. It has no significant affinity for D&lt;sub&gt;2&lt;/sub&gt;-like receptors, &amp;alpha;&lt;sub&gt;1&lt;/sub&gt; and &amp;beta;-adrenoceptors, 5&lt;sub&gt;HT1&lt;/sub&gt; and 5&lt;sub&gt;HT2&lt;/sub&gt; receptors, or muscarinic receptors. Fenoldopam is a racemic mixture with the R-isomer responsible for the biological activity. The R-isomer has approximately 250-fold higher affinity for D&lt;sub&gt;1&lt;/sub&gt;-like receptors than does the S-isomer. In non-clinical studies, fenoldopam had no agonist effect on presynaptic D&lt;sub&gt;2&lt;/sub&gt;-like dopamine receptors, or &amp;alpha; or &amp;beta; -adrenoceptors, nor did it affect angiotensin-converting enzyme activity. Fenoldopam may increase norepinephrine plasma concentration.</effect><activities/></compound><compound id="DB00714" score="1.214" srcdb="DrugBank" srcid="DB00714"><name>Apomorphine</name><SMILES>[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the acute, intermittent treatment of hypomobility, off episodes (end-of-dose wearing off and unpredictable on/off episodes) associated with advanced Parkinson's disease.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;The precise mechanism of action of apomorphine as a treatment for Parkinson's disease is unknown, although it is believed to be due to stimulation of post-synaptic dopamine D2-type receptors within the brain. Apomorphine has been shown to improve motor function in an animal model of Parkinson's disease. In particular, apomorphine attenuates the motor deficits induced by lesions in the ascending nigrostriatal dopaminergic pathway with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in primates.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="binding" geneid="1812" genename="DRD1" genesyn="None" proc="regulation of biological process" rank="29" score="0.036" simiscore="1.226" species="Homo sapiens" uniprot="P21728"><name>D(1A) dopamine receptor</name><function>This is one of the five types (D1 to D5) of receptors for dopamine. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase.</function><go_list><go branch="BP" id="GO:0007628">adult walking behavior</go><go branch="BP" id="GO:0007416">synapse assembly</go><go branch="BP" id="GO:0008542">visual learning</go><go branch="BP" id="GO:0051968">positive regulation of synaptic transmissio...</go><go branch="BP" id="GO:0030335">positive regulation of cell migration</go><go branch="BP" id="GO:0030819">positive regulation of cAMP biosynthetic pr...</go><go branch="BP" id="GO:0007617">mating behavior</go><go branch="BP" id="GO:0051482">elevation of cytosolic calcium ion concentr...</go><go branch="BP" id="GO:0042493">response to drug</go><go branch="BP" id="GO:0051281">positive regulation of release of sequester...</go><go branch="BP" id="GO:0043268">positive regulation of potassium ion transport</go><go branch="BP" id="GO:0042417">dopamine metabolic process</go><go branch="BP" id="GO:0007191">activation of adenylate cyclase activity by...</go><go branch="BP" id="GO:0021853">cerebral cortex GABAergic interneuron migra...</go><go branch="BP" id="GO:0051584">regulation of dopamine uptake</go><go branch="BP" id="GO:0060134">prepulse inhibition</go><go branch="BP" id="GO:0060158">activation of phospholipase C activity by d...</go><go branch="CC" id="GO:0005789">endoplasmic reticulum membrane</go><go branch="CC" id="GO:0005887">integral to plasma membrane</go><go branch="CC" id="GO:0005624">membrane fraction</go><go branch="MF" id="GO:0005515">protein binding</go></go_list><pathway_list><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB00800" score="1.226" srcdb="DrugBank" srcid="DB00800"><name>Fenoldopam</name><SMILES>OC1=CC=C(C=C1)C1CNCCC2=C1C=C(O)C(O)=C2Cl</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the in-hospital, short-term (up to 48 hours) management of severe hypertension when rapid, but quickly reversible, emergency reduction of blood pressure is clinically indicated, including malignant hypertension with deteriorating end-organ function.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;Fenoldopam is a rapid-acting vasodilator. It is an agonist for D&lt;sub&gt;1&lt;/sub&gt;-like dopamine receptors and binds with moderate affinity to &amp;alpha;&lt;sub&gt;2&lt;/sub&gt;-adrenoceptors. It has no significant affinity for D&lt;sub&gt;2&lt;/sub&gt;-like receptors, &amp;alpha;&lt;sub&gt;1&lt;/sub&gt; and &amp;beta;-adrenoceptors, 5&lt;sub&gt;HT1&lt;/sub&gt; and 5&lt;sub&gt;HT2&lt;/sub&gt; receptors, or muscarinic receptors. Fenoldopam is a racemic mixture with the R-isomer responsible for the biological activity. The R-isomer has approximately 250-fold higher affinity for D&lt;sub&gt;1&lt;/sub&gt;-like receptors than does the S-isomer. In non-clinical studies, fenoldopam had no agonist effect on presynaptic D&lt;sub&gt;2&lt;/sub&gt;-like dopamine receptors, or &amp;alpha; or &amp;beta; -adrenoceptors, nor did it affect angiotensin-converting enzyme activity. Fenoldopam may increase norepinephrine plasma concentration.</effect><activities/></compound><compound id="DB00714" score="1.214" srcdb="DrugBank" srcid="DB00714"><name>Apomorphine</name><SMILES>[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the acute, intermittent treatment of hypomobility, off episodes (end-of-dose wearing off and unpredictable on/off episodes) associated with advanced Parkinson's disease.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;The precise mechanism of action of apomorphine as a treatment for Parkinson's disease is unknown, although it is believed to be due to stimulation of post-synaptic dopamine D2-type receptors within the brain. Apomorphine has been shown to improve motor function in an animal model of Parkinson's disease. In particular, apomorphine attenuates the motor deficits induced by lesions in the ascending nigrostriatal dopaminergic pathway with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in primates.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="molecular transducer activity" geneid="151" genename="ADRA2B" genesyn="None" proc="cellular process" rank="30" score="0.036" simiscore="1.226" species="Homo sapiens" uniprot="P18089"><name>Alpha-2B adrenergic receptor</name><function>Alpha-2 adrenergic receptors mediate the catecholamine- induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is clonidine &gt; norepinephrine &gt; epinephrine = oxymetazoline &gt; dopamine &gt; p-tyramine = phenylephrine &gt; serotonin &gt; p-synephrine / p-octopamine. For antagonists, the rank order is yohimbine &gt; chlorpromazine &gt; phentolamine &gt; mianserine &gt; spiperone &gt; prazosin &gt; alprenolol &gt; propanolol &gt; pindolol.</function><go_list><go branch="BP" id="GO:0007186">G-protein coupled receptor protein signalin...</go><go branch="BP" id="GO:0007267">cell-cell signaling</go><go branch="CC" id="GO:0005887">integral to plasma membrane</go><go branch="MF" id="GO:0004938">alpha2-adrenergic receptor activity</go></go_list><pathway_list><react id="REACT_604" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_604">Hemostasis</react><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB00800" score="1.226" srcdb="DrugBank" srcid="DB00800"><name>Fenoldopam</name><SMILES>OC1=CC=C(C=C1)C1CNCCC2=C1C=C(O)C(O)=C2Cl</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the in-hospital, short-term (up to 48 hours) management of severe hypertension when rapid, but quickly reversible, emergency reduction of blood pressure is clinically indicated, including malignant hypertension with deteriorating end-organ function.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;Fenoldopam is a rapid-acting vasodilator. It is an agonist for D&lt;sub&gt;1&lt;/sub&gt;-like dopamine receptors and binds with moderate affinity to &amp;alpha;&lt;sub&gt;2&lt;/sub&gt;-adrenoceptors. It has no significant affinity for D&lt;sub&gt;2&lt;/sub&gt;-like receptors, &amp;alpha;&lt;sub&gt;1&lt;/sub&gt; and &amp;beta;-adrenoceptors, 5&lt;sub&gt;HT1&lt;/sub&gt; and 5&lt;sub&gt;HT2&lt;/sub&gt; receptors, or muscarinic receptors. Fenoldopam is a racemic mixture with the R-isomer responsible for the biological activity. The R-isomer has approximately 250-fold higher affinity for D&lt;sub&gt;1&lt;/sub&gt;-like receptors than does the S-isomer. In non-clinical studies, fenoldopam had no agonist effect on presynaptic D&lt;sub&gt;2&lt;/sub&gt;-like dopamine receptors, or &amp;alpha; or &amp;beta; -adrenoceptors, nor did it affect angiotensin-converting enzyme activity. Fenoldopam may increase norepinephrine plasma concentration.</effect><activities/></compound><compound id="DB00714" score="1.214" srcdb="DrugBank" srcid="DB00714"><name>Apomorphine</name><SMILES>[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the acute, intermittent treatment of hypomobility, off episodes (end-of-dose wearing off and unpredictable on/off episodes) associated with advanced Parkinson's disease.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;The precise mechanism of action of apomorphine as a treatment for Parkinson's disease is unknown, although it is believed to be due to stimulation of post-synaptic dopamine D2-type receptors within the brain. Apomorphine has been shown to improve motor function in an animal model of Parkinson's disease. In particular, apomorphine attenuates the motor deficits induced by lesions in the ascending nigrostriatal dopaminergic pathway with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in primates.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="molecular transducer activity" geneid="152" genename="ADRA2C" genesyn="None" proc="cellular process" rank="31" score="0.036" simiscore="1.226" species="Homo sapiens" uniprot="P18825"><name>Alpha-2C adrenergic receptor</name><function>Alpha-2 adrenergic receptors mediate the catecholamine- induced inhibition of adenylate cyclase through the action of G proteins.</function><go_list><go branch="BP" id="GO:0007186">G-protein coupled receptor protein signalin...</go><go branch="BP" id="GO:0000187">activation of MAPK activity</go><go branch="BP" id="GO:0007267">cell-cell signaling</go><go branch="CC" id="GO:0005768">endosome</go><go branch="CC" id="GO:0005887">integral to plasma membrane</go><go branch="MF" id="GO:0004938">alpha2-adrenergic receptor activity</go></go_list><pathway_list><react id="REACT_604" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_604">Hemostasis</react><react id="REACT_111217" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111217">Metabolism</react><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB00800" score="1.226" srcdb="DrugBank" srcid="DB00800"><name>Fenoldopam</name><SMILES>OC1=CC=C(C=C1)C1CNCCC2=C1C=C(O)C(O)=C2Cl</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the in-hospital, short-term (up to 48 hours) management of severe hypertension when rapid, but quickly reversible, emergency reduction of blood pressure is clinically indicated, including malignant hypertension with deteriorating end-organ function.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;Fenoldopam is a rapid-acting vasodilator. It is an agonist for D&lt;sub&gt;1&lt;/sub&gt;-like dopamine receptors and binds with moderate affinity to &amp;alpha;&lt;sub&gt;2&lt;/sub&gt;-adrenoceptors. It has no significant affinity for D&lt;sub&gt;2&lt;/sub&gt;-like receptors, &amp;alpha;&lt;sub&gt;1&lt;/sub&gt; and &amp;beta;-adrenoceptors, 5&lt;sub&gt;HT1&lt;/sub&gt; and 5&lt;sub&gt;HT2&lt;/sub&gt; receptors, or muscarinic receptors. Fenoldopam is a racemic mixture with the R-isomer responsible for the biological activity. The R-isomer has approximately 250-fold higher affinity for D&lt;sub&gt;1&lt;/sub&gt;-like receptors than does the S-isomer. In non-clinical studies, fenoldopam had no agonist effect on presynaptic D&lt;sub&gt;2&lt;/sub&gt;-like dopamine receptors, or &amp;alpha; or &amp;beta; -adrenoceptors, nor did it affect angiotensin-converting enzyme activity. Fenoldopam may increase norepinephrine plasma concentration.</effect><activities/></compound><compound id="DB00714" score="1.214" srcdb="DrugBank" srcid="DB00714"><name>Apomorphine</name><SMILES>[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the acute, intermittent treatment of hypomobility, off episodes (end-of-dose wearing off and unpredictable on/off episodes) associated with advanced Parkinson's disease.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;The precise mechanism of action of apomorphine as a treatment for Parkinson's disease is unknown, although it is believed to be due to stimulation of post-synaptic dopamine D2-type receptors within the brain. Apomorphine has been shown to improve motor function in an animal model of Parkinson's disease. In particular, apomorphine attenuates the motor deficits induced by lesions in the ascending nigrostriatal dopaminergic pathway with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in primates.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="catalytic activity" geneid="1017" genename="CDK2" genesyn="CDKN2" proc="regulation of biological process" rank="32" score="0.03" simiscore="1.247" species="Homo sapiens" uniprot="O75100"><name>D-HSCDK2</name><function>Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and coordinates the activation of cyclin B/CDK1 at the centrosome and in the nucleus. Crucial role in orchestrating a fine balance between cellular proliferation, cell death, and DNA repair in human embryonic stem cells (hESCs). Activity of CDK2 is maximal during S phase and G2; activated by interaction with cyclin E during the early stages of DNA synthesis to permit G1-S transition, and subsequently activated by cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA replication to drive the transition from S phase to mitosis, the G2 phase. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. Phosphorylates CABLES1 (By similarity). Cyclin E/CDK2 prevents oxidative stress-mediated Ras-induced senescence by phosphorylating MYC. Involved in G1-S phase DNA damage checkpoint that prevents cells with damaged DNA from initiating mitosis; regulates homologous recombination-dependent repair by phosphorylating BRCA2, this phosphorylation is low in S phase when recombination is active, but increases as cells progress towards mitosis. In response to DNA damage, double-strand break repair by homologous recombination a reduction of CDK2-mediated BRCA2 phosphorylation. Phosphorylation of RB1 disturbs its interaction with E2F1. NPM1 phosphorylation by cyclin E/CDK2 promotes its dissociates from unduplicated centrosomes, thus initiating centrosome duplication. Cyclin E/CDK2-mediated phosphorylation of NPAT at G1-S transition and until prophase stimulates the NPAT- mediated activation of histone gene transcription during S phase. Required for vitamin D-mediated growth inhibition by being itself inactivated. Involved in the nitric oxide- (NO) mediated signaling in a nitrosylation/activation-dependent manner. USP37 is activated by phosphorylation and thus triggers G1-S transition. CTNNB1 phosphorylation regulates insulin internalization.</function><go_list><go branch="BP" id="GO:0071732">cellular response to nitric oxide</go><go branch="BP" id="GO:0051301">cell division</go><go branch="BP" id="GO:0000084">S phase of mitotic cell cycle</go><go branch="BP" id="GO:0007089">traversing start control point of mitotic cell cycle</go><go branch="BP" id="GO:0051439">regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle</go><go branch="BP" id="GO:0016572">histone phosphorylation</go><go branch="BP" id="GO:0006275">regulation of DNA replication</go><go branch="BP" id="GO:0008284">positive regulation of cell proliferation</go><go branch="BP" id="GO:0007126">meiosis</go><go branch="BP" id="GO:0007596">blood coagulation</go><go branch="BP" id="GO:0051298">centrosome duplication</go><go branch="BP" id="GO:0007067">mitosis</go><go branch="BP" id="GO:0000086">G2/M transition of mitotic cell cycle</go><go branch="BP" id="GO:0060968">regulation of gene silencing</go><go branch="BP" id="GO:0000085">G2 phase of mitotic cell cycle</go><go branch="BP" id="GO:0000082">G1/S transition of mitotic cell cycle</go><go branch="BP" id="GO:0000216">M/G1 transition of mitotic cell cycle</go><go branch="BP" id="GO:0031145">anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process</go><go branch="BP" id="GO:0007265">Ras protein signal transduction</go><go branch="BP" id="GO:0006977">DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest</go><go branch="BP" id="GO:0006260">DNA replication</go><go branch="CC" id="GO:0005813">centrosome</go><go branch="CC" id="GO:0005829">cytosol</go><go branch="CC" id="GO:0005768">endosome</go><go branch="CC" id="GO:0000307">cyclin-dependent protein kinase holoenzyme complex</go><go branch="CC" id="GO:0015030">Cajal body</go><go branch="MF" id="GO:0005524">ATP binding</go><go branch="MF" id="GO:0004693">cyclin-dependent protein kinase activity</go></go_list><pathway_list/><compounds><compound id="DB02052" score="1.247" srcdb="DrugBank" srcid="DB02052"><name>Indirubin-3'-Monoxime</name><SMILES>O\N=C1\C(NC2=C1C=CC=C2)=C1\C(=O)NC2=C1C=CC=C2</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="binding" geneid="8851" genename="CDK5R1" genesyn="None" proc="developmental process" rank="33" score="0.03" simiscore="1.247" species="Homo sapiens" uniprot="Q15078"><name>Cyclin-dependent kinase 5 activator 1</name><function>p35 is a neuron specific activator of CDK5. The complex p35/CDK5 is required for neurite outgrowth and cortical lamination. Activator of TPKII.</function><go_list><go branch="BP" id="GO:0007158">neuron adhesion</go><go branch="BP" id="GO:0001764">neuron migration</go><go branch="BP" id="GO:0009790">embryonic development</go><go branch="BP" id="GO:0000079">regulation of cyclin-dependent protein kina...</go><go branch="BP" id="GO:0007213">muscarinic acetylcholine receptor signaling...</go><go branch="BP" id="GO:0007411">axon guidance</go><go branch="BP" id="GO:0008283">cell proliferation</go><go branch="BP" id="GO:0007420">brain development</go><go branch="BP" id="GO:0043525">positive regulation of neuron apoptosis</go><go branch="BP" id="GO:0007413">axonal fasciculation</go><go branch="BP" id="GO:0045664">regulation of neuron differentiation</go><go branch="BP" id="GO:0035235">ionotropic glutamate receptor signaling pat...</go><go branch="CC" id="GO:0048471">perinuclear region of cytoplasm</go><go branch="CC" id="GO:0043025">neuronal cell body</go><go branch="CC" id="GO:0016533">cyclin-dependent protein kinase 5 holoenzym...</go><go branch="CC" id="GO:0043292">contractile fiber</go><go branch="CC" id="GO:0005886">plasma membrane</go><go branch="CC" id="GO:0031594">neuromuscular junction</go><go branch="CC" id="GO:0030424">axon</go><go branch="CC" id="GO:0043197">dendritic spine</go><go branch="CC" id="GO:0030426">growth cone</go><go branch="MF" id="GO:0045296">cadherin binding</go><go branch="MF" id="GO:0005509">calcium ion binding</go><go branch="MF" id="GO:0016534">cyclin-dependent protein kinase 5 activator...</go></go_list><pathway_list><react id="REACT_111045" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111045">Developmental Biology</react></pathway_list><compounds><compound id="DB02052" score="1.247" srcdb="DrugBank" srcid="DB02052"><name>Indirubin-3'-Monoxime</name><SMILES>O\N=C1\C(NC2=C1C=CC=C2)=C1\C(=O)NC2=C1C=CC=C2</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="binding" geneid="2932" genename="GSK3B" genesyn="None" proc="cellular process" rank="34" score="0.03" simiscore="1.247" species="Homo sapiens" uniprot="P49841"><name>Glycogen synthase kinase-3 beta</name><function>Participates in the Wnt signaling pathway. Implicated in the hormonal control of several regulatory proteins including glycogen synthase, MYB and the transcription factor JUN. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates MUC1 in breast cancer cells, and decreases the interaction of MUC1 with CTNNB1/beta-catenin. Phosphorylates CTNNB1/beta-catenin.</function><go_list><go branch="BP" id="GO:0018105">peptidyl-serine phosphorylation</go><go branch="BP" id="GO:0006983">ER overload response</go><go branch="BP" id="GO:0005977">glycogen metabolic process</go><go branch="BP" id="GO:0060070">Wnt receptor signaling pathway through beta...</go><go branch="BP" id="GO:0043066">negative regulation of apoptosis</go><go branch="BP" id="GO:0046827">positive regulation of protein export from ...</go><go branch="BP" id="GO:0031334">positive regulation of protein complex asse...</go><go branch="BP" id="GO:0007242">intracellular signaling cascade</go><go branch="CC" id="GO:0034747">Axin-APC-beta-catenin-GSK3B complex</go><go branch="CC" id="GO:0005829">cytosol</go><go branch="CC" id="GO:0005634">nucleus</go><go branch="CC" id="GO:0030877">beta-catenin destruction complex</go><go branch="MF" id="GO:0004696">glycogen synthase kinase 3 activity</go><go branch="MF" id="GO:0002039">p53 binding</go><go branch="MF" id="GO:0050321">tau-protein kinase activity</go><go branch="MF" id="GO:0051059">NF-kappaB binding</go><go branch="MF" id="GO:0034236">protein kinase A catalytic subunit binding</go><go branch="MF" id="GO:0008013">beta-catenin binding</go><go branch="MF" id="GO:0005524">ATP binding</go></go_list><pathway_list><react id="REACT_111045" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111045">Developmental Biology</react><react id="REACT_116125" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_116125">Disease</react><react id="REACT_6900" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_6900">Immune System</react><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB02052" score="1.247" srcdb="DrugBank" srcid="DB02052"><name>Indirubin-3'-Monoxime</name><SMILES>O\N=C1\C(NC2=C1C=CC=C2)=C1\C(=O)NC2=C1C=CC=C2</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="receptor regulator activity" geneid="1020" genename="CDK5" genesyn="None" proc="developmental process" rank="35" score="0.03" simiscore="1.247" species="Homo sapiens" uniprot="Q00535"><name>Cell division protein kinase 5</name><function>Probably involved in the control of the cell cycle. Interacts with D1 and D3-type G1 cyclins. Can phosphorylate histone H1, tau, MAP2 and NF-H and NF-M. Also interacts with p35 which activates the kinase.</function><go_list><go branch="BP" id="GO:0009790">embryonic development</go><go branch="BP" id="GO:0007049">cell cycle</go><go branch="BP" id="GO:0043525">positive regulation of neuron apoptosis</go><go branch="BP" id="GO:0051301">cell division</go><go branch="BP" id="GO:0008283">cell proliferation</go><go branch="CC" id="GO:0031594">neuromuscular junction</go><go branch="CC" id="GO:0043025">neuronal cell body</go><go branch="CC" id="GO:0030424">axon</go><go branch="CC" id="GO:0030425">dendrite</go><go branch="CC" id="GO:0030426">growth cone</go><go branch="CC" id="GO:0016020">membrane</go><go branch="CC" id="GO:0030027">lamellipodium</go><go branch="CC" id="GO:0005829">cytosol</go><go branch="MF" id="GO:0005524">ATP binding</go><go branch="MF" id="GO:0004693">cyclin-dependent protein kinase activity</go><go branch="MF" id="GO:0050321">tau-protein kinase activity</go><go branch="MF" id="GO:0005176">ErbB-2 class receptor binding</go><go branch="MF" id="GO:0030549">acetylcholine receptor activator activity</go><go branch="MF" id="GO:0043125">ErbB-3 class receptor binding</go></go_list><pathway_list><react id="REACT_111045" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111045">Developmental Biology</react><react id="REACT_604" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_604">Hemostasis</react><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB02052" score="1.247" srcdb="DrugBank" srcid="DB02052"><name>Indirubin-3'-Monoxime</name><SMILES>O\N=C1\C(NC2=C1C=CC=C2)=C1\C(=O)NC2=C1C=CC=C2</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="catalytic activity" geneid="983" genename="CDK1" genesyn="None" proc="cellular process" rank="36" score="0.03" simiscore="1.247" species="Homo sapiens" uniprot="P06493"><name>Cell division control protein 2 homolog</name><function>Plays a key role in the control of the eukaryotic cell cycle by modulating the centrosome cycle as well as mitotic onset; promotes G2-M transition, and regulates G1 progress and G1-S transition via association with multiple interphase cyclins. Required in higher cells for entry into S-phase and mitosis. Phosphorylates PARVA/actopaxin, APC, AMPH, APC, BARD1, Bcl- xL/BCL2L1, BRCA2, CALD1, CASP8, CDC7, CDC20, CDC25A, CDC25C, CC2D1A, CSNK2 proteins/CKII, FZR1/CDH1, CDK7, CEBPB, DMD/dystrophin, EEF1 proteins/EF-1, EZH2, KIF11/EG5, EGFR, FANCG, FOS, GFAP, GOLGA2/GM130, GRASP1, UBE2A/hHR6A, HIST1H1 proteins/histone H1, HMGA1, HIVEP3/KRC, LMNA, LMNB, LMNC, LBR, LATS1, MAP1B, MAP4, MARCKS, MCM2, MCM4, MKLP1, MYB, NEFH, NFIC, NPC/nuclear pore complex, PITPNM1/NIR2, NPM1, NCL, NUCKS1, NPM1/numatrin, ORC1, PRKAR2A, EEF1E1/p18, EIF3F/p47, p53/TP53, NONO/p54NRB, PAPOLA, PLEC/plectin, RB1, UL40/R2, RAB4A, RAP1GAP, RCC1, RPS6KB1/S6K1, KHDRBS1/SAM68, ESPL1, SKI, BIRC5/survivin, STIP1, beta-tubulins, MAPT/TAU, NEDD1, VIM/vimentin, TK1, FOXO1, RUNX1/AML1 and RUNX2. CDK1/CDC2-cyclin-B controls pronuclear union in interphase fertilized eggs. Essential for early stages of embryonic development. During G2 and early mitosis, CDC25A/B/C- mediated dephosphorylation activates CDK1/cyclin complexes which phosphorylate several substrates that trigger at least centrosome separation, Golgi dynamics, nuclear envelope breakdown and chromosome condensation. Once chromosomes are condensed and aligned at the metaphase plate, CDK1 activity is switched off by WEE1- and PKMYT1-mediated phosphorylation to allow sister chromatid separation, chromosome decondensation, reformation of the nuclear envelope and cytokinesis. Inactivated by PKR/EIF2AK2- and WEE1-mediated phosphorylation upon DNA damage to stop cell cycle and genome replication at the G2 checkpoint thus facilitating DNA repair. Reactivated after successful DNA repair through WIP1-dependent signaling leading to CDC25A/B/C-mediated dephosphorylation and restoring cell cycle progression. In proliferating cells, CDK1-mediated FOXO1 phosphorylation at the G2-M phase represses FOXO1 interaction with 14-3-3 proteins and thereby promotes FOXO1 nuclear accumulation and transcription factor activity, leading to cell death of postmitotic neurons. The phosphorylation of beta-tubulins regulates microtubule dynamics during mitosis. NEDD1 phosphorylation promotes PLK1-mediated NEDD1 phosphorylation and subsequent targeting of the gamma-tubulin ring complex (gTuRC) to the centrosome, an important step for spindle formation. In addition, CC2D1A phosphorylation regulates CC2D1A spindle pole localization and association with SCC1/RAD21 and centriole cohesion during mitosis. The phosphorylation of Bcl- xL/BCL2L1 after prolongated G2 arrest upon DNA damage triggers apoptosis. In contrast, CASP8 phosphorylation during mitosis prevents its activation by proteolysis and subsequent apoptosis. This phosphorylation occurs in cancer cell lines, as well as in primary breast tissues and lymphocytes. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. CALD1 phosphorylation promotes Schwann cell migration during peripheral nerve regeneration.</function><go_list><go branch="BP" id="GO:0051301">cell division</go><go branch="BP" id="GO:0002756">MyD88-independent toll-like receptor signaling pathway</go><go branch="BP" id="GO:0002755">MyD88-dependent toll-like receptor signaling pathway</go><go branch="BP" id="GO:0007265">Ras protein signal transduction</go><go branch="BP" id="GO:0048011">nerve growth factor receptor signaling pathway</go><go branch="BP" id="GO:0034142">toll-like receptor 4 signaling pathway</go><go branch="BP" id="GO:0007173">epidermal growth factor receptor signaling pathway</go><go branch="BP" id="GO:0051403">stress-activated MAPK cascade</go><go branch="BP" id="GO:0000187">activation of MAPK activity</go><go branch="BP" id="GO:0000186">activation of MAPKK activity</go><go branch="BP" id="GO:0034501">protein localization to kinetochore</go><go branch="BP" id="GO:0034134">toll-like receptor 2 signaling pathway</go><go branch="BP" id="GO:0045995">regulation of embryonic development</go><go branch="BP" id="GO:0000083">regulation of transcription involved in G1/S phase of mitotic cell cycle</go><go branch="BP" id="GO:0008063">Toll signaling pathway</go><go branch="BP" id="GO:0007411">axon guidance</go><go branch="BP" id="GO:0051437">positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle</go><go branch="BP" id="GO:0007067">mitosis</go><go branch="BP" id="GO:0007098">centrosome cycle</go><go branch="BP" id="GO:0034138">toll-like receptor 3 signaling pathway</go><go branch="BP" id="GO:0007344">pronuclear fusion</go><go branch="BP" id="GO:0014038">regulation of Schwann cell differentiation</go><go branch="BP" id="GO:0006260">DNA replication</go><go branch="BP" id="GO:0016477">cell migration</go><go branch="BP" id="GO:0008286">insulin receptor signaling pathway</go><go branch="BP" id="GO:0006281">DNA repair</go><go branch="BP" id="GO:0006916">anti-apoptosis</go><go branch="BP" id="GO:0045087">innate immune response</go><go branch="BP" id="GO:0031145">anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process</go><go branch="BP" id="GO:0034130">toll-like receptor 1 signaling pathway</go><go branch="CC" id="GO:0005876">spindle microtubule</go><go branch="CC" id="GO:0005739">mitochondrion</go><go branch="CC" id="GO:0030496">midbody</go><go branch="CC" id="GO:0005829">cytosol</go><go branch="CC" id="GO:0005654">nucleoplasm</go><go branch="MF" id="GO:0005524">ATP binding</go><go branch="MF" id="GO:0008353">RNA polymerase II carboxy-terminal domain kinase activity</go><go branch="MF" id="GO:0004693">cyclin-dependent protein kinase activity</go></go_list><pathway_list><react id="REACT_6850" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_6850">Cdc20:Phospho-APC/C mediated degradation of Cyclin A</react><react id="REACT_115566" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_115566">Cell Cycle</react><react id="REACT_383" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_383">DNA Replication</react><react id="REACT_111045" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111045">Developmental Biology</react><react id="REACT_116125" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_116125">Disease</react><react id="REACT_6900" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_6900">Immune System</react><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react><react id="REACT_6782" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_6782">TRAF6 Mediated Induction of proinflammatory cytokines</react></pathway_list><compounds><compound id="DB02052" score="1.247" srcdb="DrugBank" srcid="DB02052"><name>Indirubin-3'-Monoxime</name><SMILES>O\N=C1\C(NC2=C1C=CC=C2)=C1\C(=O)NC2=C1C=CC=C2</SMILES><effect></effect><activities/></compound></compounds></target><target confirm="Predicted" fun="binding" geneid="50632" genename="CALY" genesyn="DRD1IP" proc="response to stimulus" rank="37" score="0.0" simiscore="1.214" species="Homo sapiens" uniprot="Q9NYX4"><name>D1 dopamine receptor-interacting protein calcyon</name><function>Interacts with clathrin light chain A and stimulates clathrin self-assembly and clathrin-mediated endocytosis.</function><go_list><go branch="BP" id="GO:0006897">endocytosis</go><go branch="BP" id="GO:0045807">positive regulation of endocytosis</go><go branch="BP" id="GO:0007212">dopamine receptor signaling pathway</go><go branch="BP" id="GO:0048268">clathrin coat assembly</go><go branch="CC" id="GO:0005887">integral to plasma membrane</go><go branch="CC" id="GO:0030659">cytoplasmic vesicle membrane</go><go branch="MF" id="GO:0050780">dopamine receptor binding</go><go branch="MF" id="GO:0032051">clathrin light chain binding</go></go_list><pathway_list/><compounds><compound id="DB00714" score="1.214" srcdb="DrugBank" srcid="DB00714"><name>Apomorphine</name><SMILES>[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the acute, intermittent treatment of hypomobility, off episodes (end-of-dose wearing off and unpredictable on/off episodes) associated with advanced Parkinson's disease.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;The precise mechanism of action of apomorphine as a treatment for Parkinson's disease is unknown, although it is believed to be due to stimulation of post-synaptic dopamine D2-type receptors within the brain. Apomorphine has been shown to improve motor function in an animal model of Parkinson's disease. In particular, apomorphine attenuates the motor deficits induced by lesions in the ascending nigrostriatal dopaminergic pathway with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in primates.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="binding" geneid="3358" genename="HTR2C" genesyn="HTR1C" proc="response to stimulus" rank="38" score="0.0" simiscore="1.214" species="Homo sapiens" uniprot="P28335"><name>5-hydroxytryptamine 2C receptor</name><function>This is one of the several different receptors for 5- hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system.</function><go_list><go branch="BP" id="GO:0007165">signal transduction</go><go branch="BP" id="GO:0007186">G-protein coupled receptor protein signalin...</go><go branch="BP" id="GO:0007268">synaptic transmission</go><go branch="BP" id="GO:0007631">feeding behavior</go><go branch="CC" id="GO:0005634">nucleus</go><go branch="CC" id="GO:0005886">plasma membrane</go><go branch="CC" id="GO:0005737">cytoplasm</go><go branch="CC" id="GO:0016021">integral to membrane</go><go branch="MF" id="GO:0004993">serotonin receptor activity</go><go branch="MF" id="GO:0051378">serotonin binding</go><go branch="MF" id="GO:0005515">protein binding</go></go_list><pathway_list><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB00714" score="1.214" srcdb="DrugBank" srcid="DB00714"><name>Apomorphine</name><SMILES>[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the acute, intermittent treatment of hypomobility, off episodes (end-of-dose wearing off and unpredictable on/off episodes) associated with advanced Parkinson's disease.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;The precise mechanism of action of apomorphine as a treatment for Parkinson's disease is unknown, although it is believed to be due to stimulation of post-synaptic dopamine D2-type receptors within the brain. Apomorphine has been shown to improve motor function in an animal model of Parkinson's disease. In particular, apomorphine attenuates the motor deficits induced by lesions in the ascending nigrostriatal dopaminergic pathway with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in primates.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="molecular transducer activity" geneid="3352" genename="HTR1D" genesyn="None" proc="response to stimulus" rank="39" score="0.0" simiscore="1.214" species="Homo sapiens" uniprot="P28221"><name>5-hydroxytryptamine 1D receptor</name><function>This is one of the several different receptors for 5- hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. The activity of this receptor is mediated by G proteins that inhibit adenylate cyclase activity.</function><go_list><go branch="BP" id="GO:0007268">synaptic transmission</go><go branch="BP" id="GO:0007187">G-protein signaling, coupled to cyclic nucl...</go><go branch="CC" id="GO:0005887">integral to plasma membrane</go><go branch="MF" id="GO:0004993">serotonin receptor activity</go></go_list><pathway_list><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB00714" score="1.214" srcdb="DrugBank" srcid="DB00714"><name>Apomorphine</name><SMILES>[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the acute, intermittent treatment of hypomobility, off episodes (end-of-dose wearing off and unpredictable on/off episodes) associated with advanced Parkinson's disease.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;The precise mechanism of action of apomorphine as a treatment for Parkinson's disease is unknown, although it is believed to be due to stimulation of post-synaptic dopamine D2-type receptors within the brain. Apomorphine has been shown to improve motor function in an animal model of Parkinson's disease. In particular, apomorphine attenuates the motor deficits induced by lesions in the ascending nigrostriatal dopaminergic pathway with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in primates.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="Other" geneid="1813" genename="DRD2" genesyn="None" proc="regulation of biological process" rank="40" score="0.0" simiscore="1.214" species="Homo sapiens" uniprot="P14416"><name>D(2) dopamine receptor</name><function>This is one of the five types (D1 to D5) of receptors for dopamine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase.</function><go_list><go branch="BP" id="GO:0021853">cerebral cortex GABAergic interneuron migra...</go><go branch="BP" id="GO:0051967">negative regulation of synaptic transmissio...</go><go branch="BP" id="GO:0001976">neurological system process involved in reg...</go><go branch="BP" id="GO:0002052">positive regulation of neuroblast prolifera...</go><go branch="BP" id="GO:0043266">regulation of potassium ion transport</go><go branch="BP" id="GO:0032228">regulation of synaptic transmission, GABAergic</go><go branch="BP" id="GO:0050482">arachidonic acid secretion</go><go branch="BP" id="GO:0042493">response to drug</go><go branch="BP" id="GO:0032922">circadian regulation of gene expression</go><go branch="BP" id="GO:0008104">protein localization</go><go branch="BP" id="GO:0007409">axonogenesis</go><go branch="BP" id="GO:0048149">behavioral response to ethanol</go><go branch="BP" id="GO:0048148">behavioral response to cocaine</go><go branch="BP" id="GO:0048755">branching morphogenesis of a nerve</go><go branch="BP" id="GO:0060134">prepulse inhibition</go><go branch="BP" id="GO:0030336">negative regulation of cell migration</go><go branch="BP" id="GO:0051898">negative regulation of protein kinase B sig...</go><go branch="BP" id="GO:0051586">positive regulation of dopamine uptake</go><go branch="BP" id="GO:0007270">nerve-nerve synaptic transmission</go><go branch="BP" id="GO:0048169">regulation of long-term neuronal synaptic p...</go><go branch="BP" id="GO:0008542">visual learning</go><go branch="BP" id="GO:0021984">adenohypophysis development</go><go branch="BP" id="GO:0001975">response to amphetamine</go><go branch="BP" id="GO:0030384">phosphoinositide metabolic process</go><go branch="BP" id="GO:0050709">negative regulation of protein secretion</go><go branch="BP" id="GO:0030814">regulation of cAMP metabolic process</go><go branch="BP" id="GO:0051209">release of sequestered calcium ion into cyt...</go><go branch="BP" id="GO:0002027">regulation of heart rate</go><go branch="BP" id="GO:0007195">inhibition of adenylate cyclase activity by...</go><go branch="BP" id="GO:0060158">activation of phospholipase C activity by d...</go><go branch="BP" id="GO:0002028">regulation of sodium ion transport</go><go branch="BP" id="GO:0008285">negative regulation of cell proliferation</go><go branch="BP" id="GO:0007608">sensory perception of smell</go><go branch="BP" id="GO:0030146">diuresis</go><go branch="BP" id="GO:0007416">synapse assembly</go><go branch="BP" id="GO:0042417">dopamine metabolic process</go><go branch="BP" id="GO:0008306">associative learning</go><go branch="BP" id="GO:0034776">response to histamine</go><go branch="BP" id="GO:0030432">peristalsis</go><go branch="BP" id="GO:0060124">positive regulation of growth hormone secre...</go><go branch="BP" id="GO:0043278">response to morphine</go><go branch="BP" id="GO:0001659">temperature homeostasis</go><go branch="BP" id="GO:0060160">negative regulation of dopamine receptor si...</go><go branch="BP" id="GO:0030147">natriuresis</go><go branch="BP" id="GO:0007243">protein kinase cascade</go><go branch="BP" id="GO:0007628">adult walking behavior</go><go branch="BP" id="GO:0051927">negative regulation of calcium ion transpor...</go><go branch="BP" id="GO:0045776">negative regulation of blood pressure</go><go branch="BP" id="GO:0051482">elevation of cytosolic calcium ion concentr...</go><go branch="CC" id="GO:0030424">axon</go><go branch="CC" id="GO:0005887">integral to plasma membrane</go><go branch="CC" id="GO:0030425">dendrite</go><go branch="MF" id="GO:0008144">drug binding</go><go branch="MF" id="GO:0005515">protein binding</go><go branch="MF" id="GO:0001591">dopamine receptor activity, coupled via Gi/Go</go><go branch="MF" id="GO:0015459">potassium channel regulator activity</go><go branch="MF" id="GO:0001670">dopamine D2 receptor activity</go></go_list><pathway_list><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB00714" score="1.214" srcdb="DrugBank" srcid="DB00714"><name>Apomorphine</name><SMILES>[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the acute, intermittent treatment of hypomobility, off episodes (end-of-dose wearing off and unpredictable on/off episodes) associated with advanced Parkinson's disease.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;The precise mechanism of action of apomorphine as a treatment for Parkinson's disease is unknown, although it is believed to be due to stimulation of post-synaptic dopamine D2-type receptors within the brain. Apomorphine has been shown to improve motor function in an animal model of Parkinson's disease. In particular, apomorphine attenuates the motor deficits induced by lesions in the ascending nigrostriatal dopaminergic pathway with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in primates.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="Other" geneid="1814" genename="DRD3" genesyn="None" proc="regulation of biological process" rank="41" score="0.0" simiscore="1.214" species="Homo sapiens" uniprot="P35462"><name>D(3) dopamine receptor</name><function>This is one of the five types (D1 to D5) of receptors for dopamine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase. Promotes cell proliferation.</function><go_list><go branch="BP" id="GO:0007626">locomotory behavior</go><go branch="BP" id="GO:0007191">activation of adenylate cyclase activity by...</go><go branch="BP" id="GO:0002031">G-protein coupled receptor internalization</go><go branch="BP" id="GO:0045840">positive regulation of mitosis</go><go branch="BP" id="GO:0032922">circadian regulation of gene expression</go><go branch="BP" id="GO:0048715">negative regulation of oligodendrocyte diff...</go><go branch="BP" id="GO:0048148">behavioral response to cocaine</go><go branch="BP" id="GO:0051898">negative regulation of protein kinase B sig...</go><go branch="BP" id="GO:0051584">regulation of dopamine uptake</go><go branch="BP" id="GO:0060134">prepulse inhibition</go><go branch="BP" id="GO:0014059">regulation of dopamine secretion</go><go branch="BP" id="GO:0008542">visual learning</go><go branch="BP" id="GO:0050883">musculoskeletal movement, spinal reflex action</go><go branch="BP" id="GO:0050709">negative regulation of protein secretion</go><go branch="BP" id="GO:0007195">inhibition of adenylate cyclase activity by...</go><go branch="BP" id="GO:0019216">regulation of lipid metabolic process</go><go branch="BP" id="GO:0035176">social behavior</go><go branch="BP" id="GO:0006874">cellular calcium ion homeostasis</go><go branch="BP" id="GO:0060161">positive regulation of dopamine receptor si...</go><go branch="BP" id="GO:0042417">dopamine metabolic process</go><go branch="BP" id="GO:0034776">response to histamine</go><go branch="BP" id="GO:0043278">response to morphine</go><go branch="BP" id="GO:0040014">regulation of multicellular organism growth</go><go branch="BP" id="GO:0045776">negative regulation of blood pressure</go><go branch="BP" id="GO:0042493">response to drug</go><go branch="BP" id="GO:0050482">arachidonic acid secretion</go><go branch="CC" id="GO:0005887">integral to plasma membrane</go><go branch="MF" id="GO:0008144">drug binding</go><go branch="MF" id="GO:0001592">dopamine D3 receptor activity</go></go_list><pathway_list><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB00714" score="1.214" srcdb="DrugBank" srcid="DB00714"><name>Apomorphine</name><SMILES>[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the acute, intermittent treatment of hypomobility, off episodes (end-of-dose wearing off and unpredictable on/off episodes) associated with advanced Parkinson's disease.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;The precise mechanism of action of apomorphine as a treatment for Parkinson's disease is unknown, although it is believed to be due to stimulation of post-synaptic dopamine D2-type receptors within the brain. Apomorphine has been shown to improve motor function in an animal model of Parkinson's disease. In particular, apomorphine attenuates the motor deficits induced by lesions in the ascending nigrostriatal dopaminergic pathway with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in primates.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="molecular transducer activity" geneid="3350" genename="HTR1A" genesyn="None" proc="regulation of biological process" rank="42" score="0.0" simiscore="1.214" species="Homo sapiens" uniprot="P08908"><name>5-hydroxytryptamine 1A receptor</name><function>This is one of the several different receptors for 5- hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. The activity of this receptor is mediated by G proteins that inhibit adenylate cyclase activity.</function><go_list><go branch="BP" id="GO:0007610">behavior</go><go branch="BP" id="GO:0008284">positive regulation of cell proliferation</go><go branch="CC" id="GO:0005887">integral to plasma membrane</go><go branch="MF" id="GO:0004993">serotonin receptor activity</go></go_list><pathway_list><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB00714" score="1.214" srcdb="DrugBank" srcid="DB00714"><name>Apomorphine</name><SMILES>[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the acute, intermittent treatment of hypomobility, off episodes (end-of-dose wearing off and unpredictable on/off episodes) associated with advanced Parkinson's disease.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;The precise mechanism of action of apomorphine as a treatment for Parkinson's disease is unknown, although it is believed to be due to stimulation of post-synaptic dopamine D2-type receptors within the brain. Apomorphine has been shown to improve motor function in an animal model of Parkinson's disease. In particular, apomorphine attenuates the motor deficits induced by lesions in the ascending nigrostriatal dopaminergic pathway with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in primates.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="binding" geneid="3357" genename="HTR2B" genesyn="None" proc="multicellular organismal process" rank="43" score="0.0" simiscore="1.214" species="Homo sapiens" uniprot="P41595"><name>5-hydroxytryptamine 2B receptor</name><function>This is one of the several different receptors for 5- hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system.</function><go_list><go branch="BP" id="GO:0007200">activation of phospholipase C activity by G...</go><go branch="BP" id="GO:0043123">positive regulation of I-kappaB kinase/NF-k...</go><go branch="BP" id="GO:0008015">blood circulation</go><go branch="CC" id="GO:0005887">integral to plasma membrane</go><go branch="MF" id="GO:0051378">serotonin binding</go><go branch="MF" id="GO:0004993">serotonin receptor activity</go></go_list><pathway_list><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB00714" score="1.214" srcdb="DrugBank" srcid="DB00714"><name>Apomorphine</name><SMILES>[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the acute, intermittent treatment of hypomobility, off episodes (end-of-dose wearing off and unpredictable on/off episodes) associated with advanced Parkinson's disease.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;The precise mechanism of action of apomorphine as a treatment for Parkinson's disease is unknown, although it is believed to be due to stimulation of post-synaptic dopamine D2-type receptors within the brain. Apomorphine has been shown to improve motor function in an animal model of Parkinson's disease. In particular, apomorphine attenuates the motor deficits induced by lesions in the ascending nigrostriatal dopaminergic pathway with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in primates.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="molecular transducer activity" geneid="150" genename="ADRA2A" genesyn="None" proc="cellular process" rank="44" score="0.0" simiscore="1.214" species="Homo sapiens" uniprot="P08913"><name>Alpha-2A adrenergic receptor</name><function>Alpha-2 adrenergic receptors mediate the catecholamine- induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is oxymetazoline &gt; clonidine &gt; epinephrine &gt; norepinephrine &gt; phenylephrine &gt; dopamine &gt; p-synephrine &gt; p-tyramine &gt; serotonin = p-octopamine. For antagonists, the rank order is yohimbine &gt; phentolamine = mianserine &gt; chlorpromazine = spiperone = prazosin &gt; propanolol &gt; alprenolol = pindolol.</function><go_list><go branch="BP" id="GO:0008284">positive regulation of cell proliferation</go><go branch="BP" id="GO:0007186">G-protein coupled receptor protein signalin...</go><go branch="BP" id="GO:0007266">Rho protein signal transduction</go><go branch="BP" id="GO:0000187">activation of MAPK activity</go><go branch="BP" id="GO:0007194">negative regulation of adenylate cyclase ac...</go><go branch="BP" id="GO:0030036">actin cytoskeleton organization</go><go branch="BP" id="GO:0006928">cellular component movement</go><go branch="CC" id="GO:0005887">integral to plasma membrane</go><go branch="MF" id="GO:0015459">potassium channel regulator activity</go><go branch="MF" id="GO:0004938">alpha2-adrenergic receptor activity</go></go_list><pathway_list><react id="REACT_604" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_604">Hemostasis</react><react id="REACT_111217" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111217">Metabolism</react><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB00714" score="1.214" srcdb="DrugBank" srcid="DB00714"><name>Apomorphine</name><SMILES>[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the acute, intermittent treatment of hypomobility, off episodes (end-of-dose wearing off and unpredictable on/off episodes) associated with advanced Parkinson's disease.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;The precise mechanism of action of apomorphine as a treatment for Parkinson's disease is unknown, although it is believed to be due to stimulation of post-synaptic dopamine D2-type receptors within the brain. Apomorphine has been shown to improve motor function in an animal model of Parkinson's disease. In particular, apomorphine attenuates the motor deficits induced by lesions in the ascending nigrostriatal dopaminergic pathway with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in primates.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="channel regulator activity" geneid="1815" genename="DRD4" genesyn="None" proc="cellular process" rank="45" score="0.0" simiscore="1.214" species="Homo sapiens" uniprot="P21917"><name>D(4) dopamine receptor</name><function>This is one of the five types (D1 to D5) of receptors for dopamine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase.</function><go_list><go branch="BP" id="GO:0048148">behavioral response to cocaine</go><go branch="BP" id="GO:0008344">adult locomotory behavior</go><go branch="BP" id="GO:0007195">inhibition of adenylate cyclase activity by...</go><go branch="BP" id="GO:0001662">behavioral fear response</go><go branch="BP" id="GO:0060080">regulation of inhibitory postsynaptic membr...</go><go branch="BP" id="GO:0000187">activation of MAPK activity</go><go branch="BP" id="GO:0042417">dopamine metabolic process</go><go branch="BP" id="GO:0032417">positive regulation of sodium</go><go branch="BP" id="GO:0042053">regulation of dopamine metabolic process</go><go branch="BP" id="GO:0030818">negative regulation of cAMP biosynthetic pr...</go><go branch="BP" id="GO:0048149">behavioral response to ethanol</go><go branch="BP" id="GO:0050709">negative regulation of protein secretion</go><go branch="BP" id="GO:0051927">negative regulation of calcium ion transpor...</go><go branch="BP" id="GO:0006874">cellular calcium ion homeostasis</go><go branch="BP" id="GO:0050482">arachidonic acid secretion</go><go branch="BP" id="GO:0001975">response to amphetamine</go><go branch="BP" id="GO:0035176">social behavior</go><go branch="BP" id="GO:0034776">response to histamine</go><go branch="BP" id="GO:0051586">positive regulation of dopamine uptake</go><go branch="CC" id="GO:0005887">integral to plasma membrane</go><go branch="MF" id="GO:0008144">drug binding</go><go branch="MF" id="GO:0017124">SH3 domain binding</go><go branch="MF" id="GO:0001593">dopamine D4 receptor activity</go><go branch="MF" id="GO:0015459">potassium channel regulator activity</go></go_list><pathway_list><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB00714" score="1.214" srcdb="DrugBank" srcid="DB00714"><name>Apomorphine</name><SMILES>[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the acute, intermittent treatment of hypomobility, off episodes (end-of-dose wearing off and unpredictable on/off episodes) associated with advanced Parkinson's disease.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;The precise mechanism of action of apomorphine as a treatment for Parkinson's disease is unknown, although it is believed to be due to stimulation of post-synaptic dopamine D2-type receptors within the brain. Apomorphine has been shown to improve motor function in an animal model of Parkinson's disease. In particular, apomorphine attenuates the motor deficits induced by lesions in the ascending nigrostriatal dopaminergic pathway with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in primates.</effect><activities/></compound></compounds></target><target confirm="Predicted" fun="binding" geneid="3351" genename="HTR1B" genesyn="HTR1DB" proc="response to stimulus" rank="46" score="0.0" simiscore="1.214" species="Homo sapiens" uniprot="P28222"><name>5-hydroxytryptamine 1B receptor</name><function>This is one of the several different receptors for 5- hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. The activity of this receptor is mediated by G proteins that inhibit adenylate cyclase activity.</function><go_list><go branch="BP" id="GO:0007187">G-protein signaling, coupled to cyclic nucl...</go><go branch="BP" id="GO:0007268">synaptic transmission</go><go branch="CC" id="GO:0005887">integral to plasma membrane</go><go branch="MF" id="GO:0005515">protein binding</go><go branch="MF" id="GO:0004993">serotonin receptor activity</go></go_list><pathway_list><react id="REACT_111102" link="http://www.reactome.org/cgi-bin/eventbrowser_st_id?ST_ID=REACT_111102">Signal Transduction</react></pathway_list><compounds><compound id="DB00714" score="1.214" srcdb="DrugBank" srcid="DB00714"><name>Apomorphine</name><SMILES>[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23</SMILES><effect>&lt;b&gt;Indication&lt;/b&gt;&lt;br/&gt;For the acute, intermittent treatment of hypomobility, off episodes (end-of-dose wearing off and unpredictable on/off episodes) associated with advanced Parkinson's disease.&lt;br/&gt;&lt;b&gt;Mechanism of Action&lt;/b&gt;&lt;br/&gt;The precise mechanism of action of apomorphine as a treatment for Parkinson's disease is unknown, although it is believed to be due to stimulation of post-synaptic dopamine D2-type receptors within the brain. Apomorphine has been shown to improve motor function in an animal model of Parkinson's disease. In particular, apomorphine attenuates the motor deficits induced by lesions in the ascending nigrostriatal dopaminergic pathway with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in primates.</effect><activities/></compound></compounds></target><fun-list><function name="nucleic acid binding transcription factor activity" value="1"/><function name="catalytic activity" value="17"/><function name="binding" value="14"/><function name="molecular transducer activity" value="9"/><function name="channel regulator activity" value="1"/><function name="Other" value="3"/><function name="receptor regulator activity" value="1"/></fun-list><proc-list><process name="response to stimulus" value="10"/><process name="cellular process" value="14"/><process name="regulation of biological process" value="13"/><process name="multicellular organismal process" value="2"/><process name="multi-organism process" value="1"/><process name="developmental process" value="3"/><process name="metabolic process" value="1"/><process name="Other" value="2"/></proc-list></targets>